Skip to main content
Microbial Biotechnology logoLink to Microbial Biotechnology
. 2010 Jun 24;3(4):370–388. doi: 10.1111/j.1751-7915.2009.00138.x

Adhesion determinants of the Streptococcus species

Monica Moschioni 1, Werner Pansegrau 1, Michèle A Barocchi 1,*
PMCID: PMC3815805  PMID: 21255337

Summary

Streptococci are clinically important Gram‐positive bacteria that are capable to cause a wide variety of diseases in humans and animals. Phylogenetic analyses based on 16S rRNA sequences of the streptococcal species reveal a clustering pattern, reflecting, with a few exceptions, their pathogenic potential and ecological preferences. Microbial adhesion to host tissues is the initial critical event in the pathogenesis of most infections. Streptococci use multiple adhesins to attach to the epithelium, and their expression is regulated in response to environmental and growth conditions. Bacterial adhesins recognize and bind cell surface molecules and extracellular matrix components through specific domains that for certain adhesin families have been well defined and found conserved across the streptococcal species. In this review, we present the different streptococcal adhesin families categorized on the basis of their adhesive properties and structural characteristics, and, when available, we focus the attention on conserved functional domains.

Introduction

Streptococcal species

The genus Streptococcus comprises a wide variety of species among which many are known important human pathogens. The most notable examples are Streptococcus pneumoniae, Streptococcus pyogenes and Streptococcus agalactiae. Although related, these species differ greatly in their spectrum of diseases. Streptococcus pyogenes, also known as beta‐haemolytic group A streptococcus, causes pharyngitis, scarlet fever as well as skin infections like erysipelas and impetigo; moreover, it can lead to severe invasive infections like bacteraemia, infective endocarditis, cellulitis, and necrotizing fasciitis with high mortality due to streptococcal toxic shock syndrome. Both S. pneumoniae and S. agalactiae are known as classical causes of pneumoniae, sepsis, meningitis etc., but, remarkably, the molecular mechanisms of their pathogenesis are very different. Streptococcus pneumoniae colonizes the nasopharynx in up to 40% of healthy subjects, and is a leading cause of middle ear infections, meningitis and pneumonia in children and of pneumonia and sepsis in the elderly or immunocompromised. Streptococcus agalactiae (group B streptococcus: GBS) is a common cause of neonatal pneumonia, sometimes progressing to invasive disease as a result of the aspiration of infected amniotic fluid within the uterus or vaginal secretions during parturition. More recently also other species such as S. gordonii, S. parasanguinis or S. sanguinis have emerged as important human pathogens causing infective endocarditis or acting as colonizers of dental plaque (Moreillon et al., 2002). Moreover, various streptococci are known as the cause of zoonoses in domestic and wild animals (Timoney, 2004; Agnew and Barnes, 2007; Lun et al., 2007).

Oral streptococci (approximately 20% of the oral bacteria) are primary colonizers of the tooth surface and are abundant in dental plaque biofilms, where more than 500 species or phylotypes have been identified. Bacteria growing in these relatively dense, surface‐associated communities are phenotypically quite distinct from their planktonic counterparts. The streptococci compete for adhesion binding sites on the saliva‐coated tooth surface and are able to produce antimicrobial compounds. Streptococcus mutans can, however, become dominant in oral biofilms, leading to dental caries development. Streptococcus mutans dominance depends on competition with other bacteria like S. sanguinis and S. gordonii, and is influenced by bacterial production of antimicrobial compounds, the bacteriocines (Kreth et al., 2008).

The nomenclature of Streptococcus species is rather complex as it is not only based on the species names but, for historical reasons, designations are used that are based on haemolysis type or serological grouping. In particular, Lancefield typing based on specific antisera against ‘group‐specific’ carbohydrate or lipoteichoic acid (Group D) antigens has been and is widely used to classify beta‐haemolytic streptococci. As an example it turned out, however, that S. pyogenes, for which often the terminus GAS (group A Streptococcus) is used as a synonym, is not the only Streptococcus that may possess the group A antigen because also S. anginosus or S. dysgalactiae ssp. equisimilis may carry the A antigen. On the other hand, a given streptococcal species may have several diverse types of Lancefield antigen e.g. Streptococcus dysgalactiae ssp. equisimilis may be a carrier of A, C, G or L antigens (Facklam, 2002). In the last decades phylogenetic typing based on 16S rRNA (Fig. 1) has helped the accurate identification of bacterial isolates and the discovery of novel bacteria in clinical microbiology laboratories to form a clearer picture of streptococcal species relationships. In Fig. 1 we identified in the genus Streptococcus five major clusters: S. mitis, S. mutans, S. salivarius (viridians streptococci), S. agalactiae and S. pyogenes (pyogenic group). This analysis reveals a clustering pattern reflecting the pathogenic potential and ecological preferences of the streptococcal species (Kawamura et al., 1995). One exception is the mitis group, which contains one of the leading pathogens, S. pneumoniae, along with other species that are prototype commensals of the upper respiratory tract (such as S. mitis, S. oralis or S. infantis). Recent works (Kilian et al., 2008; Bishop et al., 2009) propose the use of concatenated sequences of conserved housekeeping genes in addition to the analysis of presence/absence of virulence‐specific genes to better assign newly discovered atypical isolates, identify eventual new species, discriminate between species that are really close in terms of 16S rRNA sequences, and define in this way a standard taxonomic procedure for the genus Streptococcus.

Figure 1.

Figure 1

Phylogeny of Streptococcus species based on 16S rRNA conservation. Phylogenetic and molecular evolutionary analyses were conducted using MEGA version 4 (Tamura et al., 2004). Main groups are indicated by coloured areas. Streptococcal species in which adhesins were described are marked by filled boxes. Those species for which the complete genome is available are marked with red or yellow half circles. Red indicates that the sequence can be retrieved from NCBI, yellow indicates that the sequence is available either from The Sanger Institute or from the J.C. Venter Institute.

Adhesion in streptococci. The process of microbial infection involves a complex series of events that may result in host tissue malfunction and/or destruction. Bacterial adherence to host tissues represents a critical step in the pathogenic process and is usually mediated by bacterial surface‐exposed proteins. The latter, organized as either single molecules or ordered structures such as pili or fimbriae, are usually considered potential virulence factors and key players in the infectious process (Facklam, 2002; Mandlik et al., 2008; Proft and Baker, 2009). Most pathogenic Streptococcus species have been shown to bind to host extracellular matrix components (ECM) and cell surface molecules. In many cases, bacterial gene products involved in this interaction have not been well characterized or identified. Host ECM components known to be involved in bacterial adherence include fibronectin (Fn), collagen (usually type I, II and IV), fibrinogen (Fg), fibrin, elastin, vitronectin, laminin (Lm), as well as decorin and heparin sulfate‐containing proteoglycans (Joh et al., 1998; Moreillon et al., 2002) and salivary agglutinin glycoprotein, a constituent of the salivary film or pellicle that coats the tooth and is thought to be involved in streptococcal oral biofilm formation (dental plaque). Bacterial adhesins that specifically bind to ECM molecules are collectively termed Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMMs) (Patti et al., 1994). According to this definition, all bacterial adhesins involved in host interaction through ECM proteins, and not through a specific receptor, can be considered MSCRAMMs, despite their differences in primary sequence and molecular organization. In a single bacterial species several proteins can contribute to bacterial adhesion displaying similar adhesive properties and host protein specificity (Kreikemeyer et al., 2004, Table 1). Therefore, the ubiquitous nature of these proteins may act synergistically or as additive factors in a multifaceted adhesion process. Some of these molecules have been characterized in detail and share a significant degree of inter‐ and intra‐species sequence similarity. In this respect, especially among genetically related species like streptococci, bacterial genome dissection and sequence similarity analyses have become powerful tools to predict potential adhesin function. Here, streptococcal adhesins will be reviewed on the basis of their sequence characteristics, structural and adhesive properties, as well as their distribution among streptococcal species.

Table 1.

Streptococcal adhesins.

Species Protein References
S. mitis group
 S. pneumoniae Pilus‐1, RrgA Nelson et al. (2007); Hilleringmann et al. (2008)
PsaA Anderton et al. (2007); Rajam et al. (2008)
PspC Iannelli et al. (2002); Luo et al. (2005)
GtS Mizrachi et al. (2007)
FBA Blau et al. (2007)
6PGD Daniely et al. (2006)
PavA Holmes et al. (2001)
Psrp Obert et al. (2006)
 S. parasanguinis Fap‐1 Wu and Fives‐Taylor (1999); Froeliger and Fives‐Taylor (2001)
FimA Oligino and Fives‐Taylor (1993); Burnette‐Curley et al. (1995)
 S. sanguinis CshA Black et al. (2004)
PAAP Gong et al. (1995)
SrpA Plummer et al. (2005)
FimA Xu et al. (2007)
 S. gordonii Has Takahashi et al. (2004); Yajima et al. (2008)
GspB Takamatsu et al. (2004)
CshA, CshB McNab et al. (1995); Giomarelli et al. (2006)
SspA, SspB Egland et al. (2001); Nobbs et al. (2007)
AbpA Rogers et al. (2001)
GTF Vacca‐Smith et al. (1994)
FbpA Christie et al. (2002)
 S. cristatus SrpA Handley et al. (2005)
S. pyogenes group
 S. pyogenes Cpa, ancillary protein pilus subunit Kreikemeyer et al. (2005); Abbot et al. (2007)
F1/sfbI Talay et al. (1994); Hanski et al. (1996)
F2/PFBP Hanski et al. (1996); Jaffe et al. (1996)
SfbII/SOF Kreikemeyer et al. (1995); Timmer et al. (2006)
Fbp54 Courtney et al. (1996)
Fba, FbaB Terao et al. (2001); Terao et al. (2002b)
SfbX Jeng et al. (2003); Almengor et al. (2006)
GAPDH Pancholi and Fischetti (1992)
28 kDa protein Courtney et al. (1992)
Lbp Terao et al. (2002a)
SpeB Stockbauer et al. (1999); Hytonen et al. (2001)
M protein Courtney et al. (2002); Carlsson et al. (2005)
 S. uberis SUAM Almeida et al. (2006); Luther et al. (2008)
Lbp Moshynskyy et al. (2003)
S. agalactiae group
 S. agalactiae Pilus Dramsi et al. (2006)
BibA Santi et al. (2007)
ScpB (streptococcal C5a peptidase) Beckmann et al. (2002); Tamura et al. (2006)
Lmb Spellerberg et al. (1999)
FbsA Tenenbaum et al. (2005)
Srr‐1, Srr‐2 Samen et al. (2007)
 S. suis GAPDH Brassard et al. (2004)
Galactosyl‐alpha 1‐4‐galactose binding adhesin Tikkanen et al. (1995)
 S. dysgalactiae ssp. dysgalactiae FnbB Visai et al. (2003)
FnbA Joh et al. (1998)
 S. dysgalactiae ssp. equisimilis FnB Lindgren et al. (1994)
GfbA Kline et al. (1996)
FOG/M protein Nitsche et al. (2006)
S. mutans group
 S. mutans Adhesin P1, cell‐surface adhesion protein SA I/II Hajishengallis et al. (1994); Lee and Boran (2003)
Cnm Sato et al. (2004)
 S. equi ssp. equi SFS Lindmark and Guss (1999)
 S. equi ssp. zooepidemicus SzP Fan et al. (2008)
SFS Lindmark and Guss (1999)
FnZ, FnZ2 Lindmark et al. (1996); Hong (2005)
 S. intermedius Cell‐surface adhesion protein SA I/II Petersen et al. (2001; 2002)
 S. sobrinus SpaA/PAg Okahashi et al. (1993); Kuykindoll and Holt (1996)
 S. downei PAh Tamura et al. (2008)

Major adhesin families

Fibronectin binding

An important ubiquitous extracellular host protein targeted by a variety of streptococcal adhesins is Fn. The interaction is mediated by bacterial Fn binding proteins (FnBPs) that belong to the MSCRAMM family of adhesins (Patti et al., 1994). FnBPs in streptococci have a similar molecular organization, although the sequence length can vary considerably. They all contain an N‐terminal signal sequence, a C‐terminal cell wall LPXTG‐anchoring motif and a short positively charged C‐terminal tail (Schwarz‐Linek et al., 2006). The Fn binding activity is located in the C‐terminal half of the molecule, where sequence repeats of 30–40 residues can be found (Fn binding repeats, FnBRs); FnBRs target the N‐terminal domain (NTD) of Fn (Fig. 2A). In addition, some proteins contain an upstream Fn binding domain. Interestingly, FnBRs are intrinsically disordered regions within FnBPs. They were shown to adopt a more ordered conformation upon binding to the NTD of Fn (House‐Pompeo et al., 1996), thus defining a novel type of protein–protein interaction named ‘tandem β‐zipper’ (Schwarz‐Linek et al., 2003). Each of the repeats can potentially bind to an Fn dimer, which contains two RGD binding sites for integrins. Fibronectin, in this model of interaction, functions as a molecular bridge between the bacteria and the host cell integrins in the FnBP‐mediated bacteria internalization (Ozeri et al., 1998). It is not clear if the number of FnBRs in FnBPs is correlated to adhesion or to invasion efficiency.

Figure 2.

Figure 2

A. Domain structure of streptococcal adhesins. Functional elements are shown as black boxes while conserved signal sequences are drawn in colour. Signal peptidase recognition sequences are filled in orange, sortase recognition sequences and membrane anchor sequences are blue and green respectively. Length of boxes does not reflect the actual scale. Designations of functional elements were adapted for fibronectin binding proteins (Courtney et al., 1996), fibrinogen binding proteins (Rivera et al., 2007), AgI/II proteins (Jenkinson and Demuth, 1997), serine‐rich proteins (Seifert et al., 2006).
B. Pilus islet genes and conserved elements in pilus backbone proteins. Conserved elements and signal sequences of the backbone protein are labelled as in A. Genes are shown as boxes. In general, pilus islets encode one or two ancillary proteins, one backbone protein and one to three sortase genes. Some islets but not all encode also a Sip‐like protein.

In S. pyogenes was identified a diverse number of FnBPs, not widespread in all the isolates tested. The occurrence of several different FnBPs in S. pyogenes may be linked to the ability of the bacteria to colonize different sites in the infected host. Moreover, the combination of Fn binding with other binding activities in different FnBPs could be the basis for differential tissue tropism (Courtney et al., 2002; Kreikemeyer et al., 2004).

Among S. pyogenes FnBPs, protein F1/SfbI is the best characterized and its activity has been unequivocally linked to S. pyogenes adherence and internalization (Talay et al., 1994; Hanski et al., 1996). SfbI is present in approximately 50% of the isolates tested and contains two Fn binding domains, a repeated domain (RD2) at the C‐terminus and an additional domain located immediately N‐terminal to the RD2 (Ozeri et al., 1996). Similarly to other FnBPs, SfbI associates with host integrins through Fn, mechanism resulting in streptococcal invasion of eukaryotic cells (Cue et al., 1998). SfbI was also demonstrated to be protective in an animal model of infection (McArthur et al., 2004).

Protein F2, also called Pfbp, is different from Protein F1, it is present in most S. pyogenes strains that lack Protein F1 and binds Fn with high affinity. As demonstrated for protein F1, two distinct domains are responsible for its Fn binding activity (Hanski et al., 1996; Jaffe et al., 1996).

Interestingly, as reported below, protein F1 and F2 are both part of the pilus‐encoding locus of S. pyogenes. Possible implications of this genetic architecture are currently under investigation (Falugi et al., 2008).

An additional S. pyogenes Fg/Fn binding protein is SOF (serum opacity factor), also known as SfbII (Kreikemeyer et al., 1995; Jeng et al., 2003), a cell wall‐anchored protein able to render human serum opaque by cleaving human serum apolipoprotein. Serum opacity factor‐encoding genes exist in approximately 50% of the isolates. The SOF was demonstrated to be a S. pyogenes virulence factor in a murine infection model, and to be important in the adhesion of S. pyogenes to HEp‐2 human pharyngeal epithelial cells (Timmer et al., 2006). The role of SOF Fg binding activity in virulence has not been determined.

An additional FnBP, SfbX, is encoded by a gene immediately downstream of sof. The two genes were found expressed in the same transcription unit and sfbX was present only in sof positive isolates. Recombinant SfbX bound to immobilized Fn and partially inhibited S. pyogenes adherence to Fn (Jeng et al., 2003; Almengor et al., 2006).

In S. dysgalactiae, a species frequently associated with bovine mastitis, two FnBPs have been reported, FnbA and FnbB, homologues to S. pyogenes SfbII and Protein F2 respectively. Both proteins are able to bind Fn at multiple sites (Lindgren et al., 1993; Joh et al., 1998; Visai et al., 2003).

Similarly, in S. dysgalactiae ssp. equisimilis there is evidence for the presence of two FnBP, FnB and GfbA (Lindgren et al., 1994; Kline et al., 1996). FnB, a protein of about 120 kDa, is homologous to the corresponding FnbB of S. dysgalactiae and possesses a C‐terminal region containing three repeat units with Fn binding activity (Lindgren et al., 1994). GfbA, present in about 36% of S. dysgalactiae ssp. equisimilis isolates tested, is homologous to SfbI of S. pyogenes, contains FnBRs and mediates adherence of S. dysgalactiae ssp. equisimilis to human skin fibroblasts (Kline et al., 1996).

The obligate parasitic bacterium S. equi ssp. equi is the causative agent of strangles, a serious disease of the upper respiratory tract in horses. SFS represents a new type of FnBP, and is present in all S. equi ssp. equi isolates and in the majority of S. equi ssp. zooepidemicus tested. Interestingly, protein SFS was found to inhibit the binding between Fn and collagen in a concentration‐dependent manner (Lindmark and Guss, 1999).

Streptococcus equi ssp. zooepidemicus is frequently isolated from clinical cases of equine pneumonia and pleuropneumonia. In S. equi ssp. zooepidemicus a major FnBP is FnZ, a protein of approximately 61 kDa with a structural organization similar to that of other cell surface proteins of streptococci and staphylococci. FnZ shows a high degree of sequence similarity with SfbI of S. pyogenes. The Fn binding activity is localized to two domains in the C‐terminal part of the protein, one domain composed of five repeats (Lindmark et al., 1996). Moreover, in strains carrying FnZ, an additional FnBP was found and named FnZ2. Like FnZ, FnZ2 has the Fn binding domain localized at the C‐terminus; for this protein both Fn and collagen binding activities were demonstrated (Hong, 2005).

Several FnBPs are also known to possess additional activities, like interaction with the host immune system and specifically with complement or Fg. In this respect, the streptococcal C5a‐peptidase ScpB of GBS is a multifunctional protein found in all GBS clinical isolates and required for mucosal colonization in a neonatal mouse model of infection. ScpB is reported to inhibit neutrophil chemotaxis by enzymatically cleaving the complement component C5a and to bind to immobilized Fn (Tamura et al., 2006). Moreover, an isogenic ScpB mutant was significantly less adherent to Fn than the wild‐type strain (Beckmann et al., 2002).

PavA is a pneumococcal protein associated with pneumococcal adhesion and virulence (PavA). PavA, despite the lack of a leader peptide and a membrane‐anchoring sequence, is surface displayed. PavA specifically binds to immobilized human Fn (Holmes et al., 2001), is widespread and conserved in the pneumococcal species and homologue to S. pyogenes Fbp54 and S. gordonii FbpA (Fig. 3). Unlike classical FnBPs (see above) PavA does not possess FnBRs. PavA is responsible for approximately 50% of the S. pneumoniae Fn binding activity, suggesting the presence of additional Fn adhesins. Moreover, PavA has been shown to be critical for invasive diseases such as sepsis and meningitis (Holmes et al., 2001).

Figure 3.

Figure 3

Streptococcal adhesin homologues. Protein homologues across the Streptococcus genus are presented. A protein sequence similarity search was performed at http://blast.ncbi.nlm.nih.gov/Blast.cgi against all the streptococcal protein sequences present in the NCBI database, by using as query sequences those listed in the first column (accession numbers are reported under brackets). Proteins reported in literature to be adhesins, are marked in bold. Streptococcal species are divided on the basis of the phylogenetic analysis reported in Fig. 1. Asterisks indicate the species for which complete genome sequences are present in the NCBI database. Pilus and fimbrial components are marked in orange and dark yellow respectively.

FBP54 is another FnBP expressed on the surface of S. pyogenes and widely distributed among the S. pyogenes population. The Fn binding domain is localized at the N‐terminus of the protein, and shows no significant sequence similarity with other known Fn binding regions (Courtney et al., 1996). FBP54 blocked streptococcal adhesion to human buccal cells but had no effect on the adhesion to HEp‐2 cells.

Fn binding activity of S. gordonii is mediated by the high‐molecular‐mass protein CshA (as described below) and by FbpA (a PavA and Fbp54 homologue), a surface‐exposed protein of about 63 kDa. Purified recombinant FbpA has been shown to bind to human immobilized Fn, while isogenic S. gordonii deletion mutants were impaired in their binding to Fn. Moreover, FbpA is expressed only during exponential growth of bacteria and there is evidence that FbpA itself probably plays a regulatory role in CshA expression (Christie et al., 2002).

Interestingly, a Fn binding activity has been recognized also for proteins predicted to have an enzymatic activity and cytosolic localization, like glyceraldehyde‐3‐phosphate dehydrogenase (GAPDH). The GAPDH was described as a cytosolic enzyme, and also found on the surface of S. pyogenes and S. suis. In S. pyogenes, GAPDH, present as a tetramer on the surface, has both an enzymatic activity and binding capacity for a variety of proteins. The GAPDH is present in all S. pyogenes strains and binds to Fn and lysozyme, as well as to the cytoskeletal proteins myosin and actin. This multifunctional protein may play a role in colonization, internalization and subsequent proliferation of group A streptococci (Pancholi and Fischetti, 1992). Similarly, S. suis GAPDH is surface exposed and pre‐incubation of porcine tracheal rings with recombinant GAPDH inhibited S. suis adhesion, indicating a possible involvement of GAPDH in the first steps of bacterial adhesion to host cells (Brassard et al., 2004).

Fibrinogen binding

Fibrinogen is the major clotting protein in the blood plasma, and is critical for blood coagulation and thrombosis. Fibrinogen is primarily synthesized under normal conditions, but its synthesis is dramatically upregulated during stress and inflammation. Bacterial interaction with Fg seems to be important during infections like infective endocarditis, a disease caused by streptococci and staphylococci. The crucial step in infective endocarditis is bacterial‐induced platelet activation and subsequent aggregation that leads to plaque formation on endocardium and valve leaflets and hence to endocarditis (Fitzgerald et al., 2006; Rivera et al., 2007). Bacteria can interact with platelets directly, as below described for the S. gordonii serine‐rich proteins Hsa and GspB, or indirectly involving host proteins such as Fg that forms a link between a bacterial component and a platelet receptor.

In recent years, a number of Fg binding proteins have been described, among which one of the best characterized is the M protein of S. pyogenes. The M protein is a major virulence factor in S. pyogenes infections and is expressed in all S. pyogenes isolates. The M protein is a filamentous coiled coil dimer attached to the surface through the C‐terminus; the Fg binding domain is localized in the β‐repeat region near the N‐terminus of the protein. The β‐repeat region is composed of a variable number of repeats, with an α‐helical coiled coil conserved structure. The M protein has an anti‐phagocytic role and there is evidence that binding of Fg may be an important step in allowing S. pyogenes to escape neutrophil phagocytosis (Carlsson et al., 2005). Fg interaction is also involved in platelet thrombus formation, mediating platelet–M protein adhesion (Sjobring et al., 2002). Notably, in addition to Fg, M proteins can interact with different host serum factors including Fn, immunoglobulin, plasminogen, factor H, collagen IV and the complement regulator C4 binding protein (Courtney et al., 2002). Similarly to group A streptococci, group C and G also bind Fg trough M proteins (Schnitzler et al., 1995; Talay et al., 1996).

The FbsA protein is the Fg binding protein of S. agalactiae. The Fg binding domain has been localized in a tandem repeat region. The number of repeats varies and there is no significant sequence similarity to other streptococcal Fg binding motifs. This suggests that probably FbsA binds Fg by a unique mechanism. FbsA can also bind epithelial cells directly and block bacteria from adhering and invading epithelial cells (Tenenbaum et al., 2005). As for S. pyogenes M. protein, S. agalactiae platelet‐induced aggregation requires FbsA and is mediated by Fg (Pietrocola et al., 2005).

The group G streptococci are also equipped with Fg binding capabilities. Streptococcus dysgalactiae ssp. equisimilis (group G streptococcus: GGS) is both a human and animal pathogen of emerging clinical significance, causing skin and soft tissue infections, and occasionally resulting in sepsis and necrotizing fasciitis. The M‐like fibrinogen binding protein of GGS (FOG) is a surface protein most notably involved with Fg and collagen binding, as well as in evasion of the host immune system. Moreover, FOG expressing isolates adhere more efficiently to human skin than a FOG‐deficient strain (Nitsche et al., 2006).

Laminin binding

In the process of adhesion, ECM proteins such as Fn and Lm serve as mediators between the bacteria and host cells. Laminin, a 900 kDa glycoprotein, is a major component of the basement membrane. It is composed of three distinct polypeptide chains (A, B1 and B2) which reversibly assemble to form a macromolecular structure. Functions of Lm include the formation of the basement membrane by interaction with other basement membrane components and the development and maintenance of cellular organization. Several bacteria were demonstrated to damage the pulmonary epithelium, exposing underlying basement membrane structures. Thus, adhesion to basement membrane components may be critical for bacterial colonization of damaged epithelium and invasion of bacteria into the bloodstream.

Specific Lm binding proteins have been described for S. pyogenes and S. agalactiae. Both bacteria have been reported to directly bind to Lm. In particular, in S. agalactiae, Lmb is a lipoprotein of approximately 35 kDa, present and conserved in all the serotypes tested; its protein sequence exhibits significant similarity to the streptococcal LraI protein family, a family of surface‐associated lipoproteins involved in co‐aggregation and adherence of different streptococci. Pre‐incubation of immobilized Lm with recombinant Lmb significantly reduced adherence of S. agalactiae to Lm, indicating that Lmb mediates the attachment of S. agalactiae to human Lm (Spellerberg et al., 1999).

In S. pyogenes two distinct Lm binding proteins have been identified thus far, Lbp and SpeB (streptococcal pyrogenic exotoxin B). Lbp is a lipoprotein exhibiting a high degree of sequence similarity with GBS Lmb. Recombinant Lbp directly binds to purified human Lm and Lbp‐deficient mutants showed a significantly lower efficiency of adhesion to HEp‐2 cells than did the wild‐type strains (Terao et al., 2002a).

Streptococcal pyrogenic exotoxin B is an extracellular cysteine protease existing as three variants, one of which contains an Arg‐Gly‐Asp (RGD) sequence, a tripeptide motif that is commonly recognized by integrin receptors (Stockbauer et al., 1999). The SpeB is an extracellular protease; however, it has been shown to be surface exposed with binding activity to Lm and other glycoproteins (Hytonen et al., 2001). In addition, different activities were ascribed to SpeB: it was demonstrated to directly bind to integrins, and, as a secreted molecule to degrade host ECM proteins, thus contributing to bacterial dissemination, colonization and invasion (Kapur et al., 1993; Lukomski et al., 1998). blast sequence analysis revealed that SpeB is specific for S. pyogenes, whereas Lmb/Lbp homologues, with an extremely high degree of conservation, are present in several other Streptococcus species, including S. pneumoniae, S. gordonii and S. sanguinis (Fig. 3).

AgI/II family proteins

AgI/II family proteins are expressed by most oral streptococci and mediate interactions with salivary constituents, host cell matrix proteins, such as Fn, Fg and collagen, and with other oral bacteria, thus probably playing a role in interspecies interactions during oral biofilm formation (Jenkinson and Demuth, 1997). AgI/Il consist of a protease‐sensitive N‐terminal region, AgI, and a protease‐resistant AgIl region, represented by the C‐terminal and membrane‐proximal third of the molecule (Russell et al., 1980). The streptococcal AgI/II proteins consist of 1310–1653 amino acid residues and are structurally conserved, with seven discrete regions as deduced from the primary sequence (Fig. 2A). These include a signal (leader) peptide, an N‐terminal region (N), alanine‐rich repeat blocks (A), a divergent or variable central region (V), proline‐rich repeat blocks (P), a C‐terminal region containing a cell wall‐spanning region, a membrane‐spanning region, a cell wall anchor domain and a cytoplasmatic tail (Jenkinson and Demuth, 1997).

Streptococcus mutans, which plays a major role in tooth decay, is equipped with a cell wall‐associated multifunctional protein P1, referred to by various research groups as antigen I/II, antigen B and Pac. This protein seems to provide S. mutans with the ability to attach to the salivary pellicle on teeth (Hajishengallis et al., 1994). Structurally, P1 has a 38‐amino‐acid‐residue signal sequence (N), and an A and P region (proline rich) with each region composed of three tandem repeats. P1‐deficient cells lost the ability to aggregate in the presence of clarified whole saliva or fluid phase salivary agglutinin, and failed to adhere to saliva‐ or agglutinin‐coated hydroxyapatite beads (Lee et al., 1989; Koga et al., 1990). Crowley and colleagues (2008) identified the A region as the salivary agglutinin binding domain within the P1 molecule. Moreover, P1 interacts with Fn and Fg forming a β‐structure upon interaction with both proteins (Kelemen et al., 2004).

Streptococcus intermedius is often associated with deep‐seeded purulent infections. In S. intermedius a 160 kDa cell surface‐associated protein antigen I/II homologue to S. mutans P1 was identified (Fig. 3); unlike P1, it is not involved in adhesion to a salivary film under flowing conditions, and neither in binding to rat collagen type I. Binding to human Fn and Lm is a common function associated with the S. mutans and S. intermedius antigen I/II. In addition S. intermedius antigen I/II was demonstrated to induce interleukin 8 release by THP‐1 monocytic cells (Petersen et al., 2001; 2002; Jakubovics et al., 2005a).

SspA and SspB are two antigen I/II surface‐exposed proteins encoded by a tandem arrangement of genes in S. gordonii. The SspA and SspB proteins are > 96% identical in the N, A, P and C regions, but share only 26% identical amino acid residues in their V regions. SspA and SspB polypeptides are independently expressed and both mediate bacterial binding to surface immobilized salivary agglutinin glycoprotein and are probably involved in adhesion and initial biofilm formation on teeth by regulating the expression of multiple adhesin genes (El‐Sabaeny et al., 2000; Jakubovics et al., 2005a,b; Zhang et al., 2005). In addition, an S. gordonii deletion mutant for both SspA and SspB was reduced in adherence to HEp‐2 cells and was not internalized. Recombinant SspA and SspB polypeptides bound to purified human α5β1 integrin through sequences present within the N‐terminal region of the AgI/II polypeptide. Moreover, adherence and internalization of S. gordonii by HEp‐2 cells involves β1 integrin recognition but is not Fn‐dependent (Nobbs et al., 2007).

The SpaA protein (also refereed as PAg), a major surface protein antigen of S. sobrinus, and the S. mutans P1 protein, share 66% sequence identity at the amino acid level. As demonstrated for P1 in S. mutans, SpaA plays a role in the virulence of S. sobrinus (mostly associated with human dental caries) by specifically interacting with fluid‐phase salivary agglutinin to mediate sucrose‐dependent cell aggregation (Kuykindoll and Holt, 1996).

The pah gene of the cariogenic organism S. downei encodes a cell wall‐anchoring protein, PAh, containing 1565 amino acids. PAh shows a strong similarity to SpaA of S. sobrinus (97.6% identity). PAh is associated with the adhesion of cells to abiotic surfaces and whole saliva, as demonstrated in assays performed with wild‐type S. downei and PAh knockout mutants (Tamura et al., 2008).

Other species‐specific adhesins

Streptococcus pneumoniae

In S. pneumoniae, one of the most unique group of cell wall‐associated proteins involved in pathogenesis are the choline binding proteins (CBP). Pneumococci contain phosphorylcholine on both the cell wall teichoic acid and the membrane‐associated lipoteichoic acid. The presence of choline in the cell wall was thought to be unique to S. pneumoniae. However, recent data have indicated the presence of choline on the surface of a number of other respiratory tract pathogens like S. oralis, S. mitis, S. constellatus, Clostridium strain NI‐4, C. beijerinckii, Neisseria meningitidis, Pseudomonas aeruginosa and Haemophilus influenzae (Gosink et al., 2000). In pneumococci, the CBPs bind to the phosphorylcholine of the cell wall non‐covalently through a choline binding domain consisting of 2 –10 repeats of a 20‐amino‐acid sequence. CbpA (also referred to as PspC, SpsA Hic and PbcA) is the largest and the most abundant of the 15 Cbps identified in the genome of S. pneumoniae so far (Tettelin et al., 2001). CbpA is known for its antigenic properties, its capability to bind secretory IgA (Hammerschmidt et al., 1997) and complement factor H (Janulczyk et al., 2000), its activity as an adhesin (Rosenow et al., 1997) and in promoting invasion of epithelial cells (Zhang et al., 2000). CbpA binds specifically to the ectodomain (secretory component) of polymeric immunoglobulin receptor of epithelial cells (Zhang et al., 2000) through conserved hexapeptide motifs Y/R RNYPT located in two N‐terminal repeated domains (Elm et al., 2004). Recently, an important role in biofilm formation has been proposed for CbpA and other CBPs (LytC, PcpA, PspA) (Moscoso et al., 2006). In addition, CbpA inhibits both the classical and the alternative complement pathway declining C3 and C3b activation and deposition (Ren et al., 2003; 2004; Guiral et al., 2005).

Pneumococcal surface adhesin A is a surface‐exposed multi‐functional lipoprotein of about 37 kDa, highly conserved in the pneumococcal population and across the majority of the streptococcal species (Fig. 3). However, specific data regarding this protein are present only for S. pneumoniae, where PsaA represents one of the major and best characterized adhesins. This lipoprotein belongs to the ABC‐type transport protein complex that transports Mn2+ and Zn2+. PsaA deletion mutants are significantly less virulent than wild type, are growth‐impaired in Mn2+‐deficient environments, hypersensitive to oxidative stress, and have reduced capacity to adhere to epithelial cells (Johnston et al., 2004; Rajam et al., 2008). Moreover, Anderton et al. demonstrated that E‐cadherin, the cell junction protein in respiratory epithelial cells, is a receptor for PsaA (Anderton et al., 2007).

Recently, three additional surface proteins were shown to have a role in S. pneumoniae adhesion to epithelial cells in vitro: glutamyl tRNA synthetase (GtS), a protein of about 56 kDa and two cell wall‐localized lectins, bisphosphate aldolase (FBA) and 6‐phosphogluconate dehydrogenase (6PGD) (Daniely et al., 2006; Blau et al., 2007; Mizrachi et al., 2007).

Streptococcus agalactiae

Recently, a novel immunogenic adhesin with anti‐phagocytic activity (BibA) was identified in S. agalactiae. BibA is a multifunctional protein of approximately 65 kDa, containing a helix‐rich NTD, a proline‐rich region and a canonical LPXTG cell wall‐anchoring domain. BibA specifically binds to human C4 binding protein, a regulator of the classic complement pathway, and its deletion severely reduces the capacity of GBS to survive in human blood and to resist opsonophagocytic killing by human neutrophils. In addition, BibA knockout mutants are impaired in adhesion to cervical epithelial cells (Santi et al., 2007).

Streptococcus gordonii

In S. gordonii AbpA functions as an adhesin to amylase‐coated hydroxyapatite, in salivary‐amylase‐mediated catabolism of dietary starches and in human saliva‐supported biofilm formation. Amylase is the predominant salivary enzyme in humans and binds to S. gordonii, a primary colonizer of the teeth; this interaction is thought to be important in establishment and ecology of the oral microflora (Rogers et al., 2001).

Streptococcus gordonii is also implicated in infective endocarditis, where one of the proteins thought to play a major role in adhesion is a surface‐exposed glucosyltransferase (GTF), which mediates adhesion of S. gordonii to human umbilical vein endothelial cells in vitro and may provide a mechanism for colonization of the endocardium in infective endocarditis (Vacca‐Smith et al., 1994).

Streptococcus sanguinis

Like S. gordonii, S. sanguinis is implicated in infective endocarditis, accounting for as many as half of the cases of native valve endocarditis. Certain strains of S. sanguinis can adhere to human platelets and induce platelets to aggregate into macroscopic thrombi in vitro. The ability of S. sanguinis to induce platelets to aggregate is strongly suggested to be conferred by several separate surface components one of which, antigenically distinct, is the platelet aggregation‐associated protein (PAAP). The PAAP contains a collagen‐like immunodeterminant (PGE(P/Q)GPK) which probably interacts with a signal transducing receptor on the platelet, inducing platelet–platelet cross‐linking (Gong et al., 1995).

Streptococcus equi ssp. zooepidemicus

The M‐like protein expressed on the surface of S. equi ssp. zooepidemicus (S. zooepidemicus) is also known as SzP. SzP is similar to the M protein of group A Streptococcus in the structure and characteristics of antiphagocytosis. Like the S. pyogenes M protein, also Szp of S. zooepidemicus functions as an adhesin, and is responsible for mediating S. zooepidemicus binding to HEp‐2 cells (Fan et al., 2008).

Streptococcus suis

Streptococcus suis causes meningitis, sepsis and other serious infections in newborn and young pigs and in adult humans. Streptococcus suis adhesion to host cells was found to be mediated by the recognition of the disaccharide galactosyl‐α1‐4‐galactose through the Galα1‐4Gal binding adhesin. This adhesin, as recombinant protein, bound to latex particles inducing haemagglutination, specifically inhibited with the same inhibitors as haemagglutination stimulated by the intact bacteria (Tikkanen et al., 1995).

Streptococcus uberis

Streptococcus uberis is an important environmental pathogen that causes subclinical and clinical mastitis in lactating and non‐lactating cows throughout the world. In S. uberis mastitis key players are the bacterial lactoferrin binding activity and its capacity to adhere to bovine mammary epithelial cells. Both activities were reported for a surface protein of about 112 kDa, SUAM, whereas, Lbp was only reported to bind to bovine lactoferrin (Moshynskyy et al., 2003; Almeida et al., 2006). Lbp was present on the surface of S. uberis in monomeric and dimeric form; analysis of the primary and secondary structure suggested that Lbp is an M‐like protein.

Streptococcus mutans

Cnm is a 120 kDa protein detected in certain strains of S. mutans and involved in the cold‐agglutination. Recombinant Cnm was demonstrated to bind to immobilized collagen and Lm but not to Fn (Sato et al., 2004). Cnm homologues were found by NCBI blast analyses in other species of the S. mutans group (S. equi ssp. zooepidemicus and S. equi ssp. equi) and in S. dysgalactiae (Fig. 3).

Fimbriae

Serine‐rich proteins

Serine‐rich proteins are present in many streptococcal species. In S. parasanguinis (Fap1) and S. cristatus (SrpA), they are large glycosylated surface‐exposed proteins, demonstrated to form fimbrial‐like structures of about 400 nm in length (Handley et al., 2005) and typically involved in adhesion and virulence. These proteins are located within operons encoding a dedicated secretion system (SecA2, SecY2) and glycosyl transferases, responsible for their specific translocation and glycosylation (Bensing and Sullam, 2002).

Serine‐rich proteins (Fig. 2A) consist of an N‐terminal region predicted to contain an atypically long signal peptide, a serine‐rich region (SRR1), a region rich in basic amino acid residues (basic region), a second serine‐rich region (SRR2), and a C‐terminal cell wall sorting signal that includes an LPXTG motif (Takahashi et al., 2004).

In S. parasanguinis, isolated from human throat, blood and urine, Fap1 (fimbrial associated protein 1) is a 200 kDa protein forming long peritrichous fimbriae and responsible for S. parasanguinis adhesion to saliva‐coated hydroxyapatite. Fimbriae, composed by multiple Fap1 subunits, essentially mediate adhesion of S. parasanguinis in an in vitro tooth model and are essential for the formation of biofilm, in vivo known as dental plaque (Wu et al., 1998; Froeliger and Fives‐Taylor, 2001).

In S. sanguinis, a serine‐rich high‐molecular‐weight glycoprotein (SrpA) mediates adhesion to glycocalacin. Streptococcus sanguinis lacking SrpA showed significantly reduced binding to glycocalacin, reduced adherence to platelets and a prolonged lag time to platelet aggregation (Plummer et al., 2005).

Similarly, the surface of the oral plaque bacterium S. cristatus is decorated with a lateral tuft of fibrils, involved in the adhesion of S. cristatus to heterologous bacterial species in the plaque biofilm and composed by the serine‐rich protein SrpA (Handley et al., 2005).

In S. gordonii, two allelic variants of serine‐rich proteins have been identified, GspB and Hsa. GspB and Hsa surface expression are associated with a significant binding to human platelets (central mechanism in the pathogenesis of bacterial endocarditis) of M99 and DL1 strains respectively (Bensing and Sullam, 2002; Takahashi et al., 2002; 2004). Moreover, by binding erythrocyte surface sialoglycoproteins, these serine‐rich proteins are also involved in S. gordonii‐induced haemagglutination, which may act as an additive factor to increase the severity of endocarditis disease. More in detail, Hsa specifically binds to GPA and band 3, α 2‐3‐linked sialic acid membrane glycoproteins present on the surface of erythrocytes (Yajima et al., 2008).

Two different serine‐rich protein isoforms (Srr‐1 and Srr‐2), showing substantial differences in their primary sequences, have been reported in S. agalactiae. Adhesion data are reported only for Srr‐1; this protein was shown to interact with a 62 kDa protein in human saliva, which was identified as human keratin 4 and is involved in S. agalactiae adherence to epithelial HEp‐2 cells (Samen et al., 2007).

In S. pneumoniae only a certain number of isolates encode two sets of SecA and SecY homologues, one of which, based on sequence similarity, may constitute a specialized system for the transport of a very large serine‐rich repeat protein, named PsrP (i.e. SP1772 of S. pneumoniae TIGR4). Disruption of psrP affects the ability of the bacteria to progress into the bloodstream, presumably from the lungs, and not colonization or survival in blood (Obert et al., 2006).

Other fimbrial proteins

In S. parasanguinis FimA is a lipoprotein receptor antigen I (LraI), reported as additional component (different from the above mentioned Fap1) of surface‐exposed fimbriae. FimA, as Fap1, is involved in S. parasanguinis attachment to saliva‐coated hydroxyapatite (Oligino and Fives‐Taylor, 1993). Strains mutated in fimA continued to produce fimbriae, indicating that FimA was not the fimbrial structural subunit. Immunoelectron microscopy revealed that FimA was localized at the tips of the fimbriae (Fenno et al., 1995). Moreover, FimA was demonstrated to be an important virulence determinant of S. parasanguinis‐induced endocarditis, maybe playing a role in adherence to fibrin deposits associated with damaged cardiac valves (Burnette‐Curley et al., 1995).

Interestingly, protein blast search performed by using S. sanguinis FimA identified as homologue proteins, pilus components (GBS) or pilus hypothetical components (S. equi and S. suis) (Fig. 3). The analysis of S. sanguinis genome sequence revealed that FimA is included in an apparent pilus‐encoding locus, comprising four genes encoding for LPXTG surface‐anchored proteins (SSA_1632 to SSA_1635) flanked by a SrtC (Xu et al., 2007).

Surface fibrils of approximately 60 nm long have been identified in S. gordonii, are encoded by major cell surface polypeptides, and are termed CshA and CshB. CshA and CshB‐deficient mutants are markedly reduced in hydrophobicity, deficient in binding to oral Actinomyces species, to human Fn and to collagen I and II, and unable to colonize the oral cavities of mice (McNab et al., 1996; 1999; Giomarelli et al., 2006). Moreover, antibodies raised against S. gordonii CshA recognized on the surface of S. sanguinis and S. oralis short peritrichous fibrils, demonstrating the widespread nature of Csh‐like proteins among streptococcal species, data also confirmed by sequence similarity analysis (Fig. 3) (Elliott et al., 2003).

In the same context, an in vitro biofilm model of S. sanguinis, reproducing dental plaque biofilms, demonstrated that S. sanguinis CshA expression was significantly upregulated with respect to planktonic conditions (Black et al., 2004).

Pili

While pili in Gram‐negative bacteria have been extensively studied and recognized as important virulence factors, pili in Gram‐positive bacteria are a quite recent discovery and their distribution and role in pathogenesis is still under investigation (Mandlik et al., 2008; Proft and Baker, 2009).

Since the first identification of pili on the surface of Corynebacterium diphtheriae (Yanagawa and Honda, 1976; Ton‐That and Schneewind, 2003), pili have been found on the surface of pathogenic streptococci, such as S. pneumoniae, S. agalactiae and S. pyogenes, where they appear as long, flexible filaments protruding up to 3 µm from the cell surface (Lauer et al., 2005; Mora et al., 2005; Barocchi et al., 2006). Gram‐positive pili are composed of covalently linked subunits, the backbone pilin forming the pilus shaft and the accessory pilins, known as ancillary proteins, distributed at the pilus base and as clusters or single molecules all along the pilus filaments. The ancillary proteins are not required for pilus assembly but are involved in adhesion and pilus‐related pathogenic mechanisms (Kreikemeyer et al., 2005; Dramsi et al., 2006; LeMieux et al., 2006; Nelson et al., 2007).

Streptococcal pili are encoded by diverse genetic elements, inserted into specific genomic regions; in some streptococcal species like S. pneumoniae or S. agalactiae different pilus‐encoding islets are inserted at diverse separate loci in the genome (Bagnoli et al., 2008; Moschioni et al., 2008; Margarit et al., 2009). These islets vary in length and genetic organization, but share characteristic features. In fact, as shown in Fig. 2B, all pilus‐encoding islets contain genes encoding for LPXTG or LPXTG‐like surface‐anchored proteins (showing intra and inter‐species homology), and for sortases, specialized transpeptidases involved in pilus assembly. Moreover, some islets, e.g. PI‐2 of S. pneumoniae and three FCT regions of S. pyogenes, contain a sipA/lepA gene, coding for a signal peptidase‐like protein and essential for pilus assembly (Bagnoli et al., 2008; Zahner and Scott, 2008). Interestingly, these proteins lack essential active site residues, therefore their role in pilus biogenesis is still not clear. Detailed comparative analyses of pilin protein sequences revealed the presence of conserved characteristic sequence signatures necessary for a correct sortase‐mediated assembly (Fig. 2B). Pilin protein precursors contain: (i) an N‐terminal signal peptide for Sec‐dependent secretion, (ii) a C‐terminal cell anchor domain consisting of a membrane‐spanning region preceded by the sortase recognition motif LPXTG (or a variant thereof) followed by a hydrophobic domain and a positively charged tail, (iii) a specific amino acid sequence (WXXXVXVYPKN) termed the pilin motif, where the lysine (K) residue is required for subunit polymerization providing the ε‐amino group for intermolecular iso‐peptide bond formation, and (iv) an E‐BOX motif containing an invariant glutamate (E) demonstrated to be important for a correct pilus assembly. Following secretion of the N‐terminal part and removal of the signal peptide, the protein remains anchored to the cell membrane via the hydrophobic cell anchor domain. In a successive step sortase specifically cleaves at the LPXTG motif forming an iso‐peptide bond between C‐terminal threonyl and the epsilon amino group of the lysine residue (K) of the pilin motif linking one subunit to the other and forming the polymer (Ton‐That and Schneewind, 2004; Manzano et al., 2008; Oh et al., 2008).

Based on these data, the simplest way to identify novel pilus‐encoding islets is through a genomic approach and sequence analysis, followed by biological confirmation. Consequently, two recent publications, based on genome analyses, reported the identification of one hypothetical pilus‐encoding islet in S. suis (Fittipaldi et al., 2007), and three new islets in S. zooepidemicus (Beres et al., 2008), termed FimI, II and III.

Molecular epidemiology and genomic analyses demonstrated that all S. pyogenes and GBS isolates encode for a functional pilus, whereas in S. pneumoniae, only a minority of the isolates tested carry PI‐1 or PI‐2 (S. pneumoniae pilus‐encoding islets) suggesting possible different roles for pili in the disease outcome of these major streptococcal pathogens (Basset et al., 2007; Falugi et al., 2008; Moschioni et al., 2008; Margarit et al., 2009).

In particular, pili in S. pyogenes are encoded by at least nine different islets always inserted into the same genomic region, although differently organized and demonstrating only a low degree of sequence similarity (Falugi et al., 2008). Pili are involved in the S. pyogenes adhesion processes; in fact, S. pyogenes pilus‐deficient mutants are impaired in adhesion to human tonsil epithelium and primary human keratinocytes. The pilus adhesive properties are probably triggered by the Cpa protein, accessory component of S. pyogenes pilus; in fact, Cpa was already known as selective Collagen I binding protein before pili discovery (Kreikemeyer et al., 2005). Furthermore, S. pyogenes pili were shown to contribute to bacterial cell aggregation in liquid culture, the formation of microcolonies on human cells and the formation of biofilms (Manetti et al., 2007). Pili also contribute to S. pyogenes cell aggregation in saliva, through the saliva component Gp340, a process that is thought to play a role in host defence mechanisms (Edwards et al., 2008).

Interestingly, two well‐studied S. pyogenes FnBPs, Protein F1 and F2 (see above), are part of the pilus‐encoding islet but were not found associated with the pilus.

In S. pneumoniae, pili seem to be involved in bacterial adhesion to epithelial cells (Nelson et al., 2007; Hilleringmann et al., 2008). Bacteria lacking either PI‐1 or PI‐2 are adhesion impaired in in vitro experiments (Barocchi et al., 2006; Bagnoli et al., 2008); PI‐1 deletion mutants are also less virulent in murine models of colonization, pneumonia and bacteraemia. In pilus‐1 (also called rlrA pilus) the component involved in adhesion properties of the pilus is the ancillary protein RrgA, present in clusters at the tip and along pili filaments. Recombinant RrgA and purified pili adhered in in vitro assays to ECM components, like collagen I, Fn and Lm, thus confirming MSCRAMM properties for this protein as already revealed by detection of significant sequence similarity (Hava and Camilli, 2002; Hava et al., 2003; Nelson et al., 2007; Hilleringmann et al., 2008). Recent reports indicate a role for RrgA but not for the pilus per se in biofilm formation (Munoz‐Elias et al., 2008).

In GBS, two islets, one of which exists in two variants, code for functional pili. Recently, a potential role for the minor pilus protein of islet 2 as adhesin has been demonstrated by Dramsi et al., who showed that deletion of gbs1474, predominantly located at the pilus base but also randomly along the pilus backbone, in strain NEM316 resulted in a significant reduction of adherence to lung and cervical epithelial cells (Dramsi et al., 2006). These data taken together suggest that streptococcal pili are usually associated with virulence and adherence. Nonetheless, pili ‘per se’ are not required for host cell adhesion; in fact there is evidence that the minor pilins act as adhesins, favoured by, but independent from the pilus structure.

Conclusions

Analysis of streptococcal pathogenesis determinants has provided insight into how bacteria adhere to and invade cells, move intracellularly, and disseminate in tissues; information that has contributed to the generation of tools which address fundamental processes in cell biology. Exploring these strategies will help in the design of more technologically robust and effective biotech applications. Moreover, the plethora of experimental information gathered through in‐depth comparative genomic analyses, and in vivo/in vitro studies, makes bacterial adhesins one of the best‐studied components important for tissue‐tropisms and bacterial survival within the host. Identification of these protein components may be critical for the development of new drugs, inhibitors and vaccines.

Streptococcal adhesins have been grouped into larger families, based on the substrate with which they interact; most have distinct structures, while overlapping functions. This redundancy is not unique in nature, and may allow the bacterium to colonize or infect various hosts. The discovery and characterization of streptococcal adhesins may therefore be applied for the identification of small molecules directly targeting and inhibiting their function, thereby opening access to a more general target for therapeutic intervention. Potential synthetic adhesins could be used in the biotechnology industry as carrier molecules that deliver ‘cargo’ to specific targets, or as ‘sticky’ surfaces in aqueous preparations. These molecules may also be exploited in commercial dentistry products, as inhibitors of dental plaques, often caused by streptococcal species. Moreover, as recently suggested for streptococcal pilus subunits and several others streptococcal adhesins, these proteins, being surface exposed and expressed during crucial steps of the pathogenetic process, could be selected as vaccine components to prevent colonization and severe disease outcomes (Mora et al., 2005; Terao et al., 2005; Tai, 2006; Gianfaldoni et al., 2007; Timoney et al., 2007; Margarit et al., 2009). In addition, one may envisage novel biotechnological applications for these adhesins. Whichever their application, the role and potential applications of adhesins will be a fascinating topic to investigate in the future.

References

  1. Abbot E.L., Smith W.D., Siou G.P., Chiriboga C., Smith R.J., Wilson J.A. Pili mediate specific adhesion of Streptococcus pyogenes to human tonsil and skin. Cell Microbiol. 2007;9:1822–1833. doi: 10.1111/j.1462-5822.2007.00918.x. et al. [DOI] [PubMed] [Google Scholar]
  2. Agnew W., Barnes A.C. Streptococcus iniae: an aquatic pathogen of global veterinary significance and a challenging candidate for reliable vaccination. Vet Microbiol. 2007;122:1–15. doi: 10.1016/j.vetmic.2007.03.002. [DOI] [PubMed] [Google Scholar]
  3. Almeida R.A., Luther D.A., Park H.M., Oliver S.P. Identification, isolation, and partial characterization of a novel Streptococcus uberis adhesion molecule (SUAM) Vet Microbiol. 2006;115:183–191. doi: 10.1016/j.vetmic.2006.02.005. [DOI] [PubMed] [Google Scholar]
  4. Almengor A.C., Walters M.S., McIver K.S. Mga is sufficient to activate transcription in vitro of sof‐sfbX and other Mga‐regulated virulence genes in the group A Streptococcus. J Bacteriol. 2006;188:2038–2047. doi: 10.1128/JB.188.6.2038-2047.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Anderton J.M., Rajam G., Romero‐Steiner S., Summer S., Kowalczyk A.P., Carlone G.M. E‐cadherin is a receptor for the common protein pneumococcal surface adhesin A (PsaA) of Streptococcus pneumoniae. Microb Pathog. 2007;42:225–236. doi: 10.1016/j.micpath.2007.02.003. et al. [DOI] [PubMed] [Google Scholar]
  6. Bagnoli F., Moschioni M., Donati C., Dimitrovska V., Ferlenghi I., Facciotti C. A second pilus type in Streptococcus pneumoniae is prevalent in emerging serotypes and mediates adhesion to host cells. J Bacteriol. 2008;190:5480–5492. doi: 10.1128/JB.00384-08. et al. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Barocchi M.A., Ries J., Zogaj X., Hemsley C., Albiger B., Kanth A. A pneumococcal pilus influences virulence and host inflammatory responses. Proc Natl Acad Sci USA. 2006;103:2857–2862. doi: 10.1073/pnas.0511017103. et al. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Basset A., Trzcinski K., Hermos C., O'Brien K.L., Reid R., Santosham M. Association of the pneumococcal pilus with certain capsular serotypes but not with increased virulence. J Clin Microbiol. 2007;45:1684–1689. doi: 10.1128/JCM.00265-07. et al. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Beckmann C., Waggoner J.D., Harris T.O., Tamura G.S., Rubens C.E. Identification of novel adhesins from Group B streptococci by use of phage display reveals that C5a peptidase mediates fibronectin binding. Infect Immun. 2002;70:2869–2876. doi: 10.1128/IAI.70.6.2869-2876.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bensing B.A., Sullam P.M. An accessory sec locus of Streptococcus gordonii is required for export of the surface protein GspB and for normal levels of binding to human platelets. Mol Microbiol. 2002;44:1081–1094. doi: 10.1046/j.1365-2958.2002.02949.x. [DOI] [PubMed] [Google Scholar]
  11. Beres S.B., Sesso R., Pinto S.W., Hoe N.P., Porcella S.F., Deleo F.R., Musser J.M. Genome sequence of a Lancefield group C Streptococcus zooepidemicus strain causing epidemic nephritis: new information about an old disease. PLoS ONE. 2008;3:e3026. doi: 10.1371/journal.pone.0003026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bishop C.J., Aanensen D.M., Jordan G.E., Kilian M., Hanage W.P., Spratt B.G. Assigning strains to bacterial species via the internet. BMC Biol. 2009;7:3. doi: 10.1186/1741-7007-7-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Black C., Allan I., Ford S.K., Wilson M., McNab R. Biofilm‐specific surface properties and protein expression in oral Streptococcus sanguis. Arch Oral Biol. 2004;49:295–304. doi: 10.1016/j.archoralbio.2003.12.001. [DOI] [PubMed] [Google Scholar]
  14. Blau K., Portnoi M., Shagan M., Kaganovich A., Rom S., Kafka D. Flamingo cadherin: a putative host receptor for Streptococcus pneumoniae. J Infect Dis. 2007;195:1828–1837. doi: 10.1086/518038. et al. [DOI] [PubMed] [Google Scholar]
  15. Brassard J., Gottschalk M., Quessy S. Cloning and purification of the Streptococcus suis serotype 2 glyceraldehyde‐3‐phosphate dehydrogenase and its involvement as an adhesin. Vet Microbiol. 2004;102:87–94. doi: 10.1016/j.vetmic.2004.05.008. [DOI] [PubMed] [Google Scholar]
  16. Burnette‐Curley D., Wells V., Viscount H., Munro C.L., Fenno J.C., Fives‐Taylor P., Macrina F.L. FimA, a major virulence factor associated with Streptococcus parasanguis endocarditis. Infect Immun. 1995;63:4669–4674. doi: 10.1128/iai.63.12.4669-4674.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Carlsson F., Sandin C., Lindahl G. Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway. Mol Microbiol. 2005;56:28–39. doi: 10.1111/j.1365-2958.2005.04527.x. [DOI] [PubMed] [Google Scholar]
  18. Christie J., McNab R., Jenkinson H.F. Expression of fibronectin‐binding protein FbpA modulates adhesion in Streptococcus gordonii. Microbiology. 2002;148:1615–1625. doi: 10.1099/00221287-148-6-1615. [DOI] [PubMed] [Google Scholar]
  19. Courtney H.S., Hasty D.L., Dale J.B., Poirier T.P. A 28‐kilodalton fibronectin‐binding protein of group A streptococci. Curr Microbiol. 1992;25:245–250. doi: 10.1007/BF01575856. [DOI] [PubMed] [Google Scholar]
  20. Courtney H.S., Dale J.B., Hasty D.I. Differential effects of the streptococcal fibronectin‐binding protein, FBP54, on adhesion of group A streptococci to human buccal cells and HEp‐2 tissue culture cells. Infect Immun. 1996;64:2415–2419. doi: 10.1128/iai.64.7.2415-2419.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Courtney H.S., Hasty D.L., Dale J.B. Molecular mechanisms of adhesion, colonization, and invasion of group A Streptococci. Ann Med. 2002;34:77–87. doi: 10.1080/07853890252953464. [DOI] [PubMed] [Google Scholar]
  22. Crowley P.J., Seifert T.B., Isoda R., Van Tilburg M., Oli M.W., Robinette R.A. Requirements for surface expression and function of adhesin P1 from Streptococcus mutans. Infect Immun. 2008;76:2456–2468. doi: 10.1128/IAI.01315-07. et al. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Cue D., Dombek P.E., Lam H., Cleary P.P. Streptococcus pyogenes serotype M1 encodes multiple pathways for entry into human epithelial cells. Infect Immun. 1998;66:4593–4601. doi: 10.1128/iai.66.10.4593-4601.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Daniely D., Portnoi M., Shagan M., Porgador A., Givon‐Lavi N., Ling E. Pneumococcal 6‐phosphogluconate‐dehydrogenase, a putative adhesin, induces protective immune response in mice. Clin Exp Immunol. 2006;144:254–263. doi: 10.1111/j.1365-2249.2006.03047.x. et al. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Dramsi S., Caliot E., Bonne I., Guadagnini S., Prevost M.C., Kojadinovic M. Assembly and role of pili in group B streptococci. Mol Microbiol. 2006;60:1401–1413. doi: 10.1111/j.1365-2958.2006.05190.x. et al. [DOI] [PubMed] [Google Scholar]
  26. Edwards A.M., Manetti A.G., Falugi F., Zingaretti C., Capo S., Buccato S. Scavenger receptor gp340 aggregates group A streptococci by binding pili. Mol Microbiol. 2008;68:1378–1394. doi: 10.1111/j.1365-2958.2008.06220.x. et al. [DOI] [PubMed] [Google Scholar]
  27. Egland P.G., Du L.D., Kolenbrander P.E. Identification of independent Streptococcus gordonii SspA and SspB functions in coaggregation with Actinomyces naeslundii. Infect Immun. 2001;69:7512–7516. doi: 10.1128/IAI.69.12.7512-7516.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. El‐Sabaeny A., Demuth D.R., Park Y., Lamont R.J. Environmental conditions modulate the expression of the sspA and sspB genes in Streptococcus gordonii. Microb Pathog. 2000;29:101–113. doi: 10.1006/mpat.2000.0369. [DOI] [PubMed] [Google Scholar]
  29. Elliott D., Harrison E., Handley P.S., Ford S.K., Jaffray E., Mordan N., McNab R. Prevalence of Csh‐like fibrillar surface proteins among mitis group oral streptococci. Oral Microbiol Immunol. 2003;18:114–120. doi: 10.1034/j.1399-302x.2003.00052.x. [DOI] [PubMed] [Google Scholar]
  30. Elm C., Braathen R., Bergmann S., Frank R., Vaerman J.P., Kaetzel C.S. Ectodomains 3 and 4 of human polymeric Immunoglobulin receptor (hpIgR) mediate invasion of Streptococcus pneumoniae into the epithelium. J Biol Chem. 2004;279:6296–6304. doi: 10.1074/jbc.M310528200. et al. [DOI] [PubMed] [Google Scholar]
  31. Facklam R. What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev. 2002;15:613–630. doi: 10.1128/CMR.15.4.613-630.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Falugi F., Zingaretti C., Pinto V., Mariani M., Amodeo L., Manetti A.G. Sequence variation in group A Streptococcus pili and association of pilus backbone types with lancefield T serotypes. J Infect Dis. 2008;198:1834–1841. doi: 10.1086/593176. et al. [DOI] [PubMed] [Google Scholar]
  33. Fan H., Wang Y., Tang F., Lu C. Determination of the mimic epitope of the M‐like protein adhesin in swine Streptococcus equi subsp. zooepidemicus. BMC Microbiol. 2008;8:170. doi: 10.1186/1471-2180-8-170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Fenno J.C., Shaikh A., Spatafora G., Fives‐Taylor P. The fimA locus of Streptococcus parasanguis encodes an ATP‐binding membrane transport system. Mol Microbiol. 1995;15:849–863. doi: 10.1111/j.1365-2958.1995.tb02355.x. [DOI] [PubMed] [Google Scholar]
  35. Fittipaldi N., Gottschalk M., Vanier G., Daigle F., Harel J. Use of selective capture of transcribed sequences to identify genes preferentially expressed by Streptococcus suis upon interaction with porcine brain microvascular endothelial cells. Appl Environ Microbiol. 2007;73:4359–4364. doi: 10.1128/AEM.00258-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Fitzgerald J.R., Foster T.J., Cox D. The interaction of bacterial pathogens with platelets. Nat Rev Microbiol. 2006;4:445–457. doi: 10.1038/nrmicro1425. [DOI] [PubMed] [Google Scholar]
  37. Froeliger E.H., Fives‐Taylor P. Streptococcus parasanguis fimbria‐associated adhesin fap1 is required for biofilm formation. Infect Immun. 2001;69:2512–2519. doi: 10.1128/IAI.69.4.2512-2519.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Gianfaldoni C., Censini S., Hilleringmann M., Moschioni M., Facciotti C., Pansegrau W. Streptococcus pneumoniae pilus subunits protect mice against lethal challenge. Infect Immun. 2007;75:1059–1062. doi: 10.1128/IAI.01400-06. et al. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Giomarelli B., Visai L., Hijazi K., Rindi S., Ponzio M., Iannelli F. Binding of Streptococcus gordonii to extracellular matrix proteins. FEMS Microbiol Lett. 2006;265:172–177. doi: 10.1111/j.1574-6968.2006.00479.x. et al. [DOI] [PubMed] [Google Scholar]
  40. Gong K., Wen D.Y., Ouyang T., Rao A.T., Herzberg M.C. Platelet receptors for the Streptococcus sanguis adhesin and aggregation‐associated antigens are distinguished by anti‐idiotypical monoclonal antibodies. Infect Immun. 1995;63:3628–3633. doi: 10.1128/iai.63.9.3628-3633.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Gosink K.K., Mann E.R., Guglielmo C., Tuomanen E.I., Masure H.R. Role of novel choline binding proteins in virulence of Streptococcus pneumoniae. Infect Immun. 2000;68:5690–5695. doi: 10.1128/iai.68.10.5690-5695.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Guiral S., Mitchell T.J., Martin B., Claverys J.P. Competence‐programmed predation of noncompetent cells in the human pathogen Streptococcus pneumoniae: genetic requirements. Proc Natl Acad Sci USA. 2005;102:8710–8715. doi: 10.1073/pnas.0500879102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Hajishengallis G., Koga T., Russell M.W. Affinity and specificity of the interactions between Streptococcus mutans antigen I/II and salivary components. J Dent Res. 1994;73:1493–1502. doi: 10.1177/00220345940730090301. [DOI] [PubMed] [Google Scholar]
  44. Hammerschmidt S., Talay S.R., Brandtzaeg P., Chhatwal G.S. SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component. Mol Microbiol. 1997;25:1113–1124. doi: 10.1046/j.1365-2958.1997.5391899.x. [DOI] [PubMed] [Google Scholar]
  45. Handley P.S., Correia F.F., Russell K., Rosan B., DiRienzo J.M. Association of a novel high molecular weight, serine‐rich protein (SrpA) with fibril‐mediated adhesion of the oral biofilm bacterium Streptococcus cristatus. Oral Microbiol Immunol. 2005;20:131–140. doi: 10.1111/j.1399-302X.2004.00190.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Hanski E., Jaffe J., Ozeri V. Proteins F1 and F2 of Streptococcus pyogenes. Properties of fibronectin binding. Adv Exp Med Biol. 1996;408:141–150. doi: 10.1007/978-1-4613-0415-9_16. [DOI] [PubMed] [Google Scholar]
  47. Hava D.L., Camilli A. Large‐scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol Microbiol. 2002;45:1389–1406. [PMC free article] [PubMed] [Google Scholar]
  48. Hava D.L., Hemsley C.J., Camilli A. Transcriptional regulation in the Streptococcus pneumoniae rlrA pathogenicity islet by RlrA. J Bacteriol. 2003;185:413–421. doi: 10.1128/JB.185.2.413-421.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Hilleringmann M., Giusti F., Baudner B.C., Masignani V., Covacci A., Rappuoli R. Pneumococcal pili are composed of protofilaments exposing adhesive clusters of Rrg A. PLoS Pathog. 2008;4:e1000026. doi: 10.1371/journal.ppat.1000026. et al. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Holmes A.R., McNab R., Millsap K.W., Rohde M., Hammerschmidt S., Mawdsley J.L., Jenkinson H.F. The pavA gene of Streptococcus pneumoniae encodes a fibronectin‐binding protein that is essential for virulence. Mol Microbiol. 2001;41:1395–1408. doi: 10.1046/j.1365-2958.2001.02610.x. [DOI] [PubMed] [Google Scholar]
  51. Hong K. Identification and characterization of a novel fibronectin‐binding protein gene from Streptococcus equi subspecies zooepidemicus strain VTU211. FEMS Immunol Med Microbiol. 2005;45:231–237. doi: 10.1016/j.femsim.2005.04.006. [DOI] [PubMed] [Google Scholar]
  52. House‐Pompeo K., Xu Y., Joh D., Speziale P., Hook M. Conformational changes in the fibronectin binding MSCRAMMs are induced by ligand binding. J Biol Chem. 1996;271:1379–1384. doi: 10.1074/jbc.271.3.1379. [DOI] [PubMed] [Google Scholar]
  53. Hytonen J., Haataja S., Gerlach D., Podbielski A., Finne J. The SpeB virulence factor of Streptococcus pyogenes, a multifunctional secreted and cell surface molecule with strepadhesin, laminin‐binding and cysteine protease activity. Mol Microbiol. 2001;39:512–519. doi: 10.1046/j.1365-2958.2001.02269.x. [DOI] [PubMed] [Google Scholar]
  54. Iannelli F., Oggioni M.R., Pozzi G. Allelic variation in the highly polymorphic locus pspC of Streptococcus pneumoniae. Gene. 2002;284:63–71. doi: 10.1016/s0378-1119(01)00896-4. [DOI] [PubMed] [Google Scholar]
  55. Jaffe J., Natanson‐Yaron S., Caparon M.G., Hanski E. Protein F2, a novel fibronectin‐binding protein from Streptococcus pyogenes, possesses two binding domains. Mol Microbiol. 1996;21:373–384. doi: 10.1046/j.1365-2958.1996.6331356.x. [DOI] [PubMed] [Google Scholar]
  56. Jakubovics N.S., Kerrigan S.W., Nobbs A.H., Stromberg N., Van Dolleweerd C.J., Cox D.M. Functions of cell surface‐anchored antigen I/II family and Hsa polypeptides in interactions of Streptococcus gordonii with host receptors. Infect Immun. 2005a;73:6629–6638. doi: 10.1128/IAI.73.10.6629-6638.2005. et al. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Jakubovics N.S., Stromberg N., Van Dolleweerd C.J., Kelly C.G., Jenkinson H.F. Differential binding specificities of oral streptococcal antigen I/II family adhesins for human or bacterial ligands. Mol Microbiol. 2005b;55:1591–1605. doi: 10.1111/j.1365-2958.2005.04495.x. [DOI] [PubMed] [Google Scholar]
  58. Janulczyk R., Iannelli F., Sjoholm A.G., Pozzi G., Bjorck L. Hic, a novel surface protein of Streptococcus pneumoniae that interferes with complement function. J Biol Chem. 2000;275:37257–37263. doi: 10.1074/jbc.M004572200. [DOI] [PubMed] [Google Scholar]
  59. Jeng A., Sakota V., Li Z., Datta V., Beall B., Nizet V. Molecular genetic analysis of a group A Streptococcus operon encoding serum opacity factor and a novel fibronectin‐binding protein, SfbX. J Bacteriol. 2003;185:1208–1217. doi: 10.1128/JB.185.4.1208-1217.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Jenkinson H.F., Demuth D.R. Structure, function and immunogenicity of streptococcal antigen I/II polypeptides. Mol Microbiol. 1997;23:183–190. doi: 10.1046/j.1365-2958.1997.2021577.x. [DOI] [PubMed] [Google Scholar]
  61. Joh D., Speziale P., Gurusiddappa S., Manor J., Hook M. Multiple specificities of the staphylococcal and streptococcal fibronectin‐binding microbial surface components recognizing adhesive matrix molecules. Eur J Biochem. 1998;258:897–905. doi: 10.1046/j.1432-1327.1998.2580897.x. [DOI] [PubMed] [Google Scholar]
  62. Johnston J.W., Myers L.E., Ochs M.M., Benjamin W.H., Jr, Briles D.E., Hollingshead S.K. Lipoprotein PsaA in virulence of Streptococcus pneumoniae: surface accessibility and role in protection from superoxide. Infect Immun. 2004;72:5858–5867. doi: 10.1128/IAI.72.10.5858-5867.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Kapur V., Topouzis S., Majesky M.W., Li L.L., Hamrick M.R., Hamill R.J. A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. Microb Pathog. 1993;15:327–346. doi: 10.1006/mpat.1993.1083. et al. [DOI] [PubMed] [Google Scholar]
  64. Kawamura Y., Hou X.G., Sultana F., Miura H., Ezaki T. Determination of 16S rRNA sequences of Streptococcus mitis and Streptococcus gordonii and phylogenetic relationships among members of the genus Streptococcus. Int J Syst Bacteriol. 1995;45:406–408. doi: 10.1099/00207713-45-2-406. [DOI] [PubMed] [Google Scholar]
  65. Kelemen L., Rizk S., Debreczeny M., Ogier J., Szalontai B. Streptococcal antigen I/II binds to extracellular proteins through intermolecular beta‐sheets. FEBS Lett. 2004;566:190–194. doi: 10.1016/j.febslet.2004.04.029. [DOI] [PubMed] [Google Scholar]
  66. Kilian M., Poulsen K., Blomqvist T., Havarstein L.S., Bek‐Thomsen M., Tettelin H., Sorensen U.B. Evolution of Streptococcus pneumoniae and its close commensal relatives. PLoS ONE. 2008;3:e2683. doi: 10.1371/journal.pone.0002683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Kline J.B., Xu S., Bisno A.L., Collins C.M. Identification of a fibronectin‐binding protein (GfbA) in pathogenic group G streptococci. Infect Immun. 1996;64:2122–2129. doi: 10.1128/iai.64.6.2122-2129.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Koga T., Okahashi N., Takahashi I., Kanamoto T., Asakawa H., Iwaki M. Surface hydrophobicity, adherence, and aggregation of cell surface protein antigen mutants of Streptococcus mutans serotype c. Infect Immun. 1990;58:289–296. doi: 10.1128/iai.58.2.289-296.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Kreikemeyer B., Talay S.R., Chhatwal G.S. Characterization of a novel fibronectin‐binding surface protein in group A streptococci. Mol Microbiol. 1995;17:137–145. doi: 10.1111/j.1365-2958.1995.mmi_17010137.x. [DOI] [PubMed] [Google Scholar]
  70. Kreikemeyer B., Klenk M., Podbielski A. The intracellular status of Streptococcus pyogenes: role of extracellular matrix‐binding proteins and their regulation. Int J Med Microbiol. 2004;294:177–188. doi: 10.1016/j.ijmm.2004.06.017. [DOI] [PubMed] [Google Scholar]
  71. Kreikemeyer B., Nakata M., Oehmcke S., Gschwendtner C., Normann J., Podbielski A. Streptococcus pyogenes collagen type I‐binding Cpa surface protein. Expression profile, binding characteristics, biological functions, and potential clinical impact. J Biol Chem. 2005;280:33228–33239. doi: 10.1074/jbc.M502896200. [DOI] [PubMed] [Google Scholar]
  72. Kreth J., Zhang Y., Herzberg M.C. Streptococcal antagonism in oral biofilms: Streptococcus sanguinis and Streptococcus gordonii interference with Streptococcus mutans. J Bacteriol. 2008;190:4632–4640. doi: 10.1128/JB.00276-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Kuykindoll R.J., Holt R.G. Characterization of a P1‐deficient strain of Streptococcus mutans that expresses the SpaA protein of Streptococcus sobrinus. Infect Immun. 1996;64:3652–3658. doi: 10.1128/iai.64.9.3652-3658.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Lauer P., Rinaudo C.D., Soriani M., Margarit I., Maione D., Rosini R. Genome analysis reveals pili in Group B Streptococcus. Science. 2005;309:105. doi: 10.1126/science.1111563. et al. [DOI] [PubMed] [Google Scholar]
  75. LeMieux J., Hava D.L., Basset A., Camilli A. RrgA and RrgB are components of a multisubunit pilus encoded by the Streptococcus pneumoniae rlrA pathogenicity islet. Infect Immun. 2006;74:2453–2456. doi: 10.1128/IAI.74.4.2453-2456.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Lee S.F., Boran T.L. Roles of sortase in surface expression of the major protein adhesin P1, saliva‐induced aggregation and adherence, and cariogenicity of Streptococcus mutans. Infect Immun. 2003;71:676–681. doi: 10.1128/IAI.71.2.676-681.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Lee S.F., Progulske‐Fox A., Erdos G.W., Piacentini D.A., Ayakawa G.Y., Crowley P.J., Bleiweis A.S. Construction and characterization of isogenic mutants of Streptococcus mutans deficient in major surface protein antigen P1 (I/II) Infect Immun. 1989;57:3306–3313. doi: 10.1128/iai.57.11.3306-3313.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Lindgren P.E., McGavin M.J., Signas C., Guss B., Gurusiddappa S., Hook M., Lindberg M. Two different genes coding for fibronectin‐binding proteins from Streptococcus dysgalactiae. The complete nucleotide sequences and characterization of the binding domains. Eur J Biochem. 1993;214:819–827. doi: 10.1111/j.1432-1033.1993.tb17985.x. [DOI] [PubMed] [Google Scholar]
  79. Lindgren P.E., Signas C., Rantamaki L., Lindberg M. A fibronectin‐binding protein from Streptococcus equisimilis: characterization of the gene and identification of the binding domain. Vet Microbiol. 1994;41:235–247. doi: 10.1016/0378-1135(94)90104-x. [DOI] [PubMed] [Google Scholar]
  80. Lindmark H., Guss B. SFS, a novel fibronectin‐binding protein from Streptococcus equi, inhibits the binding between fibronectin and collagen. Infect Immun. 1999;67:2383–2388. doi: 10.1128/iai.67.5.2383-2388.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Lindmark H., Jacobsson K., Frykberg L., Guss B. Fibronectin‐binding protein of Streptococcus equi subsp. zooepidemicus. Infect Immun. 1996;64:3993–3999. doi: 10.1128/iai.64.10.3993-3999.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Lukomski S., Burns E.H., Jr, Wyde P.R., Podbielski A., Rurangirwa J., Moore‐Poveda D.K., Musser J.M. Genetic inactivation of an extracellular cysteine protease (SpeB) expressed by Streptococcus pyogenes decreases resistance to phagocytosis and dissemination to organs. Infect Immun. 1998;66:771–776. doi: 10.1128/iai.66.2.771-776.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Lun Z.R., Wang Q.P., Chen X.G., Li A.X., Zhu X.Q. Streptococcus suis: an emerging zoonotic pathogen. Lancet Infect Dis. 2007;7:201–209. doi: 10.1016/S1473-3099(07)70001-4. [DOI] [PubMed] [Google Scholar]
  84. Luo R., Mann B., Lewis W.S., Rowe A., Heath R., Stewart M.L. Solution structure of choline binding protein A, the major adhesin of Streptococcus pneumoniae. EMBO J. 2005;24:34–43. doi: 10.1038/sj.emboj.7600490. et al. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Luther D.A., Almeida R.A., Oliver S.P. Elucidation of the DNA sequence of Streptococcus uberis adhesion molecule gene (sua) and detection of sua in strains of Streptococcus uberis isolated from geographically diverse locations. Vet Microbiol. 2008;128:304–312. doi: 10.1016/j.vetmic.2007.10.015. [DOI] [PubMed] [Google Scholar]
  86. McArthur J., Medina E., Mueller A., Chin J., Currie B.J., Sriprakash K.S. Intranasal vaccination with streptococcal fibronectin binding protein Sfb1 fails to prevent growth and dissemination of Streptococcus pyogenes in a murine skin infection model. Infect Immun. 2004;72:7342–7345. doi: 10.1128/IAI.72.12.7342-7345.2004. et al. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. McNab R., Tannock G.W., Jenkinson H.F. Characterization of CshA, a high molecular mass adhesin of Streptococcus gordonii. Dev Biol Stand. 1995;85:371–375. [PubMed] [Google Scholar]
  88. McNab R., Holmes A.R., Clarke J.M., Tannock G.W., Jenkinson H.F. Cell surface polypeptide CshA mediates binding of Streptococcus gordonii to other oral bacteria and to immobilized fibronectin. Infect Immun. 1996;64:4204–4210. doi: 10.1128/iai.64.10.4204-4210.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. McNab R., Forbes H., Handley P.S., Loach D.M., Tannock G.W., Jenkinson H.F. Cell wall‐anchored CshA polypeptide (259 kilodaltons) in Streptococcus gordonii forms surface fibrils that confer hydrophobic and adhesive properties. J Bacteriol. 1999;181:3087–3095. doi: 10.1128/jb.181.10.3087-3095.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Mandlik A., Swierczynski A., Das A., Ton‐That H. Pili in Gram‐positive bacteria: assembly, involvement in colonization and biofilm development. Trends Microbiol. 2008;16:33–40. doi: 10.1016/j.tim.2007.10.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Manetti A.G., Zingaretti C., Falugi F., Capo S., Bombaci M., Bagnoli F. Streptococcus pyogenes pili promote pharyngeal cell adhesion and biofilm formation. Mol Microbiol. 2007;64:968–983. doi: 10.1111/j.1365-2958.2007.05704.x. et al. [DOI] [PubMed] [Google Scholar]
  92. Manzano C., Contreras‐Martel C., El M.L., Izore T., Fenel D., Vernet T. Sortase‐mediated pilus fiberbiogenesis in Streptococcus pneumoniae. Structure. 2008;16:1838–1848. doi: 10.1016/j.str.2008.10.007. et al. [DOI] [PubMed] [Google Scholar]
  93. Margarit I., Rinaudo C.D., Galeotti C.L., Maione D., Ghezzo C., Buttazzoni E. Preventing bacterial infections with pilus‐based vaccines: the group B streptococcus paradigm. J Infect Dis. 2009;199:108–115. doi: 10.1086/595564. et al. [DOI] [PubMed] [Google Scholar]
  94. Mizrachi N.Y., Bernstein A., Portnoi M., Shagan M., Rom S., Porgador A., Dagan R. Streptococcus pneumoniae surface‐exposed glutamyl tRNA synthetase, a putative adhesin, is able to induce a partially protective immune response in mice. J Infect Dis. 2007;196:945–953. doi: 10.1086/521028. [DOI] [PubMed] [Google Scholar]
  95. Mora M., Bensi G., Capo S., Falugi F., Zingaretti C., Manetti A.G. Group A Streptococcus produce pilus‐like structures containing protective antigens and Lancefield T antigens. Proc Natl Acad Sci USA. 2005;102:15641–15646. doi: 10.1073/pnas.0507808102. et al. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Moreillon P., Que Y.A., Bayer A.S. Pathogenesis of streptococcal and staphylococcal endocarditis. Infect Dis Clin North Am. 2002;16:297–318. doi: 10.1016/s0891-5520(01)00009-5. [DOI] [PubMed] [Google Scholar]
  97. Moschioni M., Donati C., Muzzi A., Masignani V., Censini S., Hanage W.P. Streptococcus pneumoniae contains 3 rlrA pilus variants that are clonally related. J Infect Dis. 2008;197:888–896. doi: 10.1086/528375. et al. [DOI] [PubMed] [Google Scholar]
  98. Moscoso M., Garcia E., Lopez R. Biofilm formation by Streptococcus pneumoniae: role of choline, extracellular DNA, and capsular polysaccharide in microbial accretion. J Bacteriol. 2006;188:7785–7795. doi: 10.1128/JB.00673-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Moshynskyy I., Jiang M., Fontaine M.C., Perez‐Casal J., Babiuk L.A., Potter A.A. Characterization of a bovine lactoferrin binding protein of Streptococcus uberis. Microb Pathog. 2003;35:203–215. doi: 10.1016/s0882-4010(03)00150-5. [DOI] [PubMed] [Google Scholar]
  100. Munoz‐Elias E.J., Marcano J., Camilli A. Isolation of Streptococcus pneumoniae biofilm mutants and their characterization during nasopharyngeal colonization. Infect Immun. 2008;76:5049–5061. doi: 10.1128/IAI.00425-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Nelson A.L., Ries J., Bagnoli F., Dahlberg S., Falker S., Rounioja S. RrgA is a pilus‐associated adhesin in Streptococcus pneumoniae. Mol Microbiol. 2007;66:329–340. doi: 10.1111/j.1365-2958.2007.05908.x. et al. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Nitsche D.P., Johansson H.M., Frick I.M., Morgelin M. Streptococcal protein FOG, a novel matrix adhesin interacting with collagen I in vivo. J Biol Chem. 2006;281:1670–1679. doi: 10.1074/jbc.M506776200. [DOI] [PubMed] [Google Scholar]
  103. Nobbs A.H., Shearer B.H., Drobni M., Jepson M.A., Jenkinson H.F. Adherence and internalization of Streptococcus gordonii by epithelial cells involves beta1 integrin recognition by SspA and SspB (antigen I/II family) polypeptides. Cell Microbiol. 2007;9:65–83. doi: 10.1111/j.1462-5822.2006.00768.x. [DOI] [PubMed] [Google Scholar]
  104. Obert C., Sublett J., Kaushal D., Hinojosa E., Barton T., Tuomanen E.I., Orihuela C.J. Identification of a Candidate Streptococcus pneumoniae core genome and regions of diversity correlated with invasive pneumococcal disease. Infect Immun. 2006;74:4766–4777. doi: 10.1128/IAI.00316-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Oh S.Y., Budzik J.M., Schneewind O. Sortases make pili from three ingredients. Proc Natl Acad Sci USA. 2008;105:13703–13704. doi: 10.1073/pnas.0807334105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Okahashi N., Takahashi I., Nakai M., Senpuku H., Nisizawa T., Koga T. Identification of antigenic epitopes in an alanine‐rich repeating region of a surface protein antigen of Streptococcus mutants. Infect Immun. 1993;61:1301–1306. doi: 10.1128/iai.61.4.1301-1306.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Oligino L., Fives‐Taylor P. Overexpression and purification of a fimbria‐associated adhesin of Streptococcus parasanguis. Infect Immun. 1993;61:1016–1022. doi: 10.1128/iai.61.3.1016-1022.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Ozeri V., Tovi A., Burstein I., Natanson‐Yaron S., Caparon M.G., Yamada K.M. A two‐domain mechanism for group A streptococcal adherence through protein F to the extracellular matrix. EMBO J. 1996;15:989–998. et al. [PMC free article] [PubMed] [Google Scholar]
  109. Ozeri V., Rosenshine I., Mosher D.F., Fassler R., Hanski E. Roles of integrins and fibronectin in the entry of Streptococcus pyogenes into cells via protein F1. Mol Microbiol. 1998;30:625–637. doi: 10.1046/j.1365-2958.1998.01097.x. [DOI] [PubMed] [Google Scholar]
  110. Pancholi V., Fischetti V.A. A major surface protein on group A streptococci is a glyceraldehyde‐3‐phosphate‐dehydrogenase with multiple binding activity. J Exp Med. 1992;176:415–426. doi: 10.1084/jem.176.2.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Patti J.M., Allen B.L., McGavin M.J., Hook M. MSCRAMM‐mediated adherence of microorganisms to host tissues. Annu Rev Microbiol. 1994;48:585–617. doi: 10.1146/annurev.mi.48.100194.003101. [DOI] [PubMed] [Google Scholar]
  112. Petersen F.C., Pasco S., Ogier J., Klein J.P., Assev S., Scheie A.A. Expression and functional properties of the Streptococcus intermedius surface protein antigen I/II. Infect Immun. 2001;69:4647–4653. doi: 10.1128/IAI.69.7.4647-4653.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Petersen F.C., Assev S., Van Der Mei H.C., Busscher H.J., Scheie A.A. Functional variation of the antigen I/II surface protein in Streptococcus mutans and Streptococcus intermedius. Infect Immun. 2002;70:249–256. doi: 10.1128/IAI.70.1.249-256.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Pietrocola G., Schubert A., Visai L., Torti M., Fitzgerald J.R., Foster T.J. FbsA, a fibrinogen‐binding protein from Streptococcus agalactiae, mediates platelet aggregation. Blood. 2005;105:1052–1059. doi: 10.1182/blood-2004-06-2149. et al. [DOI] [PubMed] [Google Scholar]
  115. Plummer C., Wu H., Kerrigan S.W., Meade G., Cox D., Ian Douglas C.W. A serine‐rich glycoprotein of Streptococcus sanguis mediates adhesion to platelets via GPIb. Br J Haematol. 2005;129:101–109. doi: 10.1111/j.1365-2141.2005.05421.x. [DOI] [PubMed] [Google Scholar]
  116. Proft T., Baker E.N. Pili in Gram‐negative and Gram‐positive bacteria – structure, assembly and their role in disease. Cell Mol Life Sci. 2009;66:613–635. doi: 10.1007/s00018-008-8477-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Rajam G., Anderton J.M., Carlone G.M., Sampson J.S., Ades E.W. Pneumococcal Surface Adhesin A (PsaA): a review. Crit Rev Microbiol. 2008;34:163–173. doi: 10.1080/10408410802383610. [DOI] [PubMed] [Google Scholar]
  118. Ren B., Szalai A.J., Thomas O., Hollingshead S.K., Briles D.E. Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae. Infect Immun. 2003;71:75–85. doi: 10.1128/IAI.71.1.75-85.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Ren B., Szalai A.J., Hollingshead S.K., Briles D.E. Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface. Infect Immun. 2004;72:114–122. doi: 10.1128/IAI.72.1.114-122.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Rivera J., Vannakambadi G., Hook M., Speziale P. Fibrinogen‐binding proteins of Gram‐positive bacteria. Thromb Haemost. 2007;98:503–511. [PubMed] [Google Scholar]
  121. Rogers J.D., Palmer R.J., Jr, Kolenbrander P.E., Scannapieco F.A. Role of Streptococcus gordonii amylase‐binding protein A in adhesion to hydroxyapatite, starch metabolism, and biofilm formation. Infect Immun. 2001;69:7046–7056. doi: 10.1128/IAI.69.11.7046-7056.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Rosenow C., Ryan P., Weiser J.N., Johnson S., Fontan P., Ortqvist A., Masure H.R. Contribution of novel choline‐binding proteins to adherence, colonization andimmunogenicity of Streptococcus pneumoniae. Mol Microbiol. 1997;25:819–829. doi: 10.1111/j.1365-2958.1997.mmi494.x. [DOI] [PubMed] [Google Scholar]
  123. Russell M.W., Bergmeier L.A., Zanders E.D., Lehner T. Protein antigens of Streptococcus mutans: purification and properties of a double antigen and its protease‐resistant component. Infect Immun. 1980;28:486–493. doi: 10.1128/iai.28.2.486-493.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Samen U., Eikmanns B.J., Reinscheid D.J., Borges F. The surface protein Srr‐1 of Streptococcus agalactiae binds human keratin 4 and promotes adherence to epithelial HEp‐2 cells. Infect Immun. 2007;75:5405–5414. doi: 10.1128/IAI.00717-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Santi I., Scarselli M., Mariani M., Pezzicoli A., Masignani V., Taddei A. BibA: a novel immunogenic bacterial adhesin contributing to group B Streptococcus survival in human blood. Mol Microbiol. 2007;63:754–767. doi: 10.1111/j.1365-2958.2006.05555.x. et al. [DOI] [PubMed] [Google Scholar]
  126. Sato Y., Okamoto K., Kagami A., Yamamoto Y., Igarashi T., Kizaki H. Streptococcus mutans strains harboring collagen‐binding adhesin. J Dent Res. 2004;83:534–539. doi: 10.1177/154405910408300705. [DOI] [PubMed] [Google Scholar]
  127. Schnitzler N., Podbielski A., Baumgarten G., Mignon M., Kaufhold A. M or M‐like protein gene polymorphisms in human group G streptococci. J Clin Microbiol. 1995;33:356–363. doi: 10.1128/jcm.33.2.356-363.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Schwarz‐Linek U., Werner J.M., Pickford A.R., Gurusiddappa S., Kim J.H., Pilka E.S. Pathogenic bacteria attach to human fibronectin through a tandem beta‐zipper. Nature. 2003;423:177–181. doi: 10.1038/nature01589. et al. [DOI] [PubMed] [Google Scholar]
  129. Schwarz‐Linek U., Hook M., Potts J.R. Fibronectin‐binding proteins of gram‐positive cocci. Microbes Infect. 2006;8:2291–2298. doi: 10.1016/j.micinf.2006.03.011. [DOI] [PubMed] [Google Scholar]
  130. Seifert K.N., Adderson E.E., Whiting A.A., Bohnsack J.F., Crowley P.J., Brady L.J. A unique serine‐rich repeat protein (Srr‐2) and novel surface antigen (epsilon) associated with a virulent lineage of serotype III Streptococcus agalactiae. Microbiology. 2006;152:1029–1040. doi: 10.1099/mic.0.28516-0. [DOI] [PubMed] [Google Scholar]
  131. Sjobring U., Ringdahl U., Ruggeri Z.M. Induction of platelet thrombi by bacteria and antibodies. Blood. 2002;100:4470–4477. doi: 10.1182/blood-2002-01-0069. [DOI] [PubMed] [Google Scholar]
  132. Spellerberg B., Rozdzinski E., Martin S., Weber‐Heynemann J., Schnitzler N., Lutticken R., Podbielski A. Lmb, a protein with similarities to the LraI adhesin family, mediates attachment of Streptococcus agalactiae to human laminin. Infect Immun. 1999;67:871–878. doi: 10.1128/iai.67.2.871-878.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Stockbauer K.E., Magoun L., Liu M., Burns E.H., Jr, Gubba S., Renish S. A natural variant of the cysteine protease virulence factor of group A Streptococcus with an arginine‐glycine‐aspartic acid (RGD) motif preferentially binds human integrins alphavbeta3 and alphaIIbbeta3. Proc Natl Acad Sci USA. 1999;96:242–247. doi: 10.1073/pnas.96.1.242. et al. [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Tai S.S. Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies. Crit Rev Microbiol. 2006;32:139–153. doi: 10.1080/10408410600822942. [DOI] [PubMed] [Google Scholar]
  135. Takahashi Y., Konishi K., Cisar J.O., Yoshikawa M. Identification and characterization of hsa, the gene encoding the sialic acid‐binding adhesin of Streptococcus gordonii DL1. Infect Immun. 2002;70:1209–1218. doi: 10.1128/IAI.70.3.1209-1218.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Takahashi Y., Yajima A., Cisar J.O., Konishi K. Functional analysis of the Streptococcus gordonii DL1 sialic acid‐binding adhesin and its essential role in bacterial binding to platelets. Infect Immun. 2004;72:3876–3882. doi: 10.1128/IAI.72.7.3876-3882.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Takamatsu D., Bensing B.A., Sullam P.M. Four proteins encoded in the gspB‐secY2A2 operon of Streptococcus gordonii mediate the intracellular glycosylation of the platelet‐binding protein GspB. J Bacteriol. 2004;186:7100–7111. doi: 10.1128/JB.186.21.7100-7111.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Talay S.R., Valentin‐Weigand P., Timmis K.N., Chhatwal G.S. Domain structure and conserved epitopes of Sfb protein, the fibronectin‐binding adhesin of Streptococcus pyogenes. Mol Microbiol. 1994;13:531–539. doi: 10.1111/j.1365-2958.1994.tb00448.x. [DOI] [PubMed] [Google Scholar]
  139. Talay S.R., Grammel M.P., Chhatwal G.S. Structure of a group C streptococcal protein that binds to fibrinogen, albumin and immunoglobulin G via overlapping modules. Biochem J. 1996;315:577–582. doi: 10.1042/bj3150577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Tamura K., Nei M., Kumar S. Prospects for inferring very large phylogenies by using the neighbor‐joining method. Proc Natl Acad Sci USA. 2004;101:11030–11035. doi: 10.1073/pnas.0404206101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Tamura G.S., Hull J.R., Oberg M.D., Castner D.G. High‐affinity interaction between fibronectin and the group B streptococcal C5a peptidase is unaffected by a naturally occurring four‐amino‐acid deletion that eliminates peptidase activity. Infect Immun. 2006;74:5739–5746. doi: 10.1128/IAI.00241-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Tamura H., Yamada A., Kato H. Identification and characterization of an antigen I/II homologous gene, pah, from Streptococcus downei. Curr Microbiol. 2008;56:518–523. doi: 10.1007/s00284-008-9117-9. [DOI] [PubMed] [Google Scholar]
  143. Tenenbaum T., Bloier C., Adam R., Reinscheid D.J., Schroten H. Adherence to and invasion of human brain microvascular endothelial cells are promoted by fibrinogen‐binding protein FbsA of Streptococcus agalactiae. Infect Immun. 2005;73:4404–4409. doi: 10.1128/IAI.73.7.4404-4409.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Terao Y., Kawabata S., Kunitomo E., Murakami J., Nakagawa I., Hamada S. Fba, a novel fibronectin‐binding protein from Streptococcus pyogenes, promotes bacterial entry into epithelial cells, and the fba gene is positively transcribed under the Mga regulator. Mol Microbiol. 2001;42:75–86. doi: 10.1046/j.1365-2958.2001.02579.x. [DOI] [PubMed] [Google Scholar]
  145. Terao Y., Kawabata S., Kunitomo E., Nakagawa I., Hamada S. Novel laminin‐binding protein of Streptococcus pyogenes, Lbp, is involved in adhesion to epithelial cells. Infect Immun. 2002a;70:993–997. doi: 10.1128/iai.70.2.993-997.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Terao Y., Kawabata S., Nakata M., Nakagawa I., Hamada S. Molecular characterization of a novel fibronectin‐binding protein of Streptococcus pyogenes strains isolated from toxic shock‐like syndrome patients. J Biol Chem. 2002b;277:47428–47435. doi: 10.1074/jbc.M209133200. [DOI] [PubMed] [Google Scholar]
  147. Terao Y., Okamoto S., Kataoka K., Hamada S., Kawabata S. Protective immunity against Streptococcus pyogenes challenge in mice after immunization with fibronectin‐binding protein. J Infect Dis. 2005;192:2081–2091. doi: 10.1086/498162. [DOI] [PubMed] [Google Scholar]
  148. Tettelin H., Nelson K.E., Paulsen I.T., Eisen J.A., Read T.D., Peterson S. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science. 2001;293:498–506. doi: 10.1126/science.1061217. et al. [DOI] [PubMed] [Google Scholar]
  149. Tikkanen K., Haataja S., Francois‐Gerard C., Finne J. Purification of a galactosyl‐alpha 1‐4‐galactose‐binding adhesin from the gram‐positive meningitis‐associated bacterium Streptococcus suis. J Biol Chem. 1995;270:28874–28878. doi: 10.1074/jbc.270.48.28874. [DOI] [PubMed] [Google Scholar]
  150. Timmer A.M., Kristian S.A., Datta V., Jeng A., Gillen C.M., Walker M.J. Serum opacity factor promotes group A streptococcal epithelial cell invasion and virulence. Mol Microbiol. 2006;62:15–25. doi: 10.1111/j.1365-2958.2006.05337.x. et al. [DOI] [PubMed] [Google Scholar]
  151. Timoney J.F. The pathogenic equine streptococci. Vet Res. 2004;35:397–409. doi: 10.1051/vetres:2004025. [DOI] [PubMed] [Google Scholar]
  152. Timoney J.F., Qin A., Muthupalani S., Artiushin S. Vaccine potential of novel surface exposed and secreted proteins of Streptococcus equi. Vaccine. 2007;25:5583–5590. doi: 10.1016/j.vaccine.2007.02.040. [DOI] [PubMed] [Google Scholar]
  153. Ton‐That H., Schneewind O. Assembly of pili on the surface of Corynebacterium diphtheriae. Mol Microbiol. 2003;50:1429–1438. doi: 10.1046/j.1365-2958.2003.03782.x. [DOI] [PubMed] [Google Scholar]
  154. Ton‐That H., Schneewind O. Assembly of pili in Gram‐positive bacteria. Trends Microbiol. 2004;12:228–234. doi: 10.1016/j.tim.2004.03.004. [DOI] [PubMed] [Google Scholar]
  155. Vacca‐Smith A.M., Jones C.A., Levine M.J., Stinson M.W. Glucosyltransferase mediates adhesion of Streptococcus gordonii to human endothelial cells in vitro. Infect Immun. 1994;62:2187–2194. doi: 10.1128/iai.62.6.2187-2194.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  156. Visai L., De R.E., Valtulina V., Casolini F., Rindi S., Guglierame P. Identification and characterization of a new ligand‐binding site in FnbB, a fibronectin‐binding adhesin from Streptococcus dysgalactiae. Biochim Biophys Acta. 2003;1646:173–183. doi: 10.1016/s1570-9639(03)00020-7. et al. [DOI] [PubMed] [Google Scholar]
  157. Wu H., Fives‐Taylor P.M. Identification of dipeptide repeats and a cell wall sorting signal in the fimbriae‐associated adhesin, Fap1, of Streptococcus parasanguis. Mol Microbiol. 1999;34:1070–1081. doi: 10.1046/j.1365-2958.1999.01670.x. [DOI] [PubMed] [Google Scholar]
  158. Wu H., Mintz K.P., Ladha M., Fives‐Taylor P.M. Isolation and characterization of Fap1, a fimbriae‐associated adhesin of Streptococcus parasanguis FW213. Mol Microbiol. 1998;28:487–500. doi: 10.1046/j.1365-2958.1998.00805.x. [DOI] [PubMed] [Google Scholar]
  159. Xu P., Alves J.M., Kitten T., Brown A., Chen Z., Ozaki L.S. Genome of the opportunistic pathogen Streptococcus sanguinis. J Bacteriol. 2007;189:3166–3175. doi: 10.1128/JB.01808-06. et al. [DOI] [PMC free article] [PubMed] [Google Scholar]
  160. Yajima A., Urano‐Tashiro Y., Shimazu K., Takashima E., Takahashi Y., Konishi K. Hsa, an adhesin of Streptococcus gordonii DL1, binds to alpha2‐3‐linked sialic acid on glycophorin A of the erythrocyte membrane. Microbiol Immunol. 2008;52:69–77. doi: 10.1111/j.1348-0421.2008.00015.x. [DOI] [PubMed] [Google Scholar]
  161. Yanagawa R., Honda E. Presence of pili in species of human and animal parasites and pathogens of the genus corynebacterium. Infect Immun. 1976;13:1293–1295. doi: 10.1128/iai.13.4.1293-1295.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  162. Zahner D., Scott J.R. SipA is required for pilus formation in Streptococcus pyogenes serotype M3. J Bacteriol. 2008;190:527–535. doi: 10.1128/JB.01520-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. Zhang J.R., Mostov K.E., Lamm M.E., Nanno M., Shimida S., Ohwaki M., Tuomanen E. The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell. 2000;102:827–837. doi: 10.1016/s0092-8674(00)00071-4. [DOI] [PubMed] [Google Scholar]
  164. Zhang Y., Lei Y., Nobbs A., Khammanivong A., Herzberg M.C. Inactivation of Streptococcus gordonii SspAB alters expression of multiple adhesin genes. Infect Immun. 2005;73:3351–3357. doi: 10.1128/IAI.73.6.3351-3357.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Microbial biotechnology are provided here courtesy of Wiley

RESOURCES